Download:
pdf |
pdfNational Birth Defects Prevention Study – Related Publications
- NBDPS Pooled Data Only -
Published/In Press Manuscripts
2015
1.
Arth A, Tinker S, Moore C, Canfield M, Agopian A, Reefhuis J. Supplement use and other
characteristics among pregnant women with a previous pregnancy affected by a neural tube
defect-United States, 1997-2009. MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):6-9.
2.
Carmichael SL, Ma C, Rasmussen SA, Cunningham ML, Browne ML, Dosiou C, Lammer EJ,
Shaw GM. Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A.
2015 April; 167(4):707-7.
3.
Howards PP, Johnson CY, Honein MA, Flanders WD and the National Birth Defects
Prevention Study. Adjusting for Bias Due to Incomplete Case Ascertainment in Case-Control
Studies of Birth Defects. Am J Epidemiol. 2015 March 19. [Epub ahead of print].
4.
Lim H, Agopian AJ, Whitehead LW, Beasley CW, Langlois PH, Emery RJ, Waller DK and the
National Birth Defects Prevention Study. Maternal occupational exposure to ionizing radiation
and major structural birth defects. Birth Defects Res A Clin Mol Teratol. 2015 March 28. [Epub
ahead of print].
5.
Michalski AM, Richardson SD, Browne ML, Carmichael SL, Canfield MA, VanZutphen AR,
Anderka MT, Marshall EG, Druschel CM. Sex ratios among infants with birth defects, National
Birth Defects Prevention Study, 1997-2009. Am J Med Genet A. 2015 Feb 25. [Epub ahead of
print].
6.
Vinikoor-Imler LC, Stewart TG, Luben TJ, Davis JA, Langlois PH. An exploratory analysis of
the relationship between ambient ozone and particulate matter concentrations during early
pregnancy and selected birth defects in Texas. Environ Pollut. 2015 March 14; 202:1-6. [Epub
ahead of print].
7.
Vuong AM, Shinde MU, Brender JD, Shipp EM, Huber JC Jr., Zheng Q, McDonald TJ,
Sharkey JR, Hoyt AT, Werler MM, Kelley KE, Langlois PH, Canfield MA and the National
Birth Defects Prevention Study. Nitrosatable Drug Exposure during Pregnancy and Preterm and
Small-for-Gestational-Age Births. Paediatr Perinat Epidemiol. 2015 Jan;29(1):60-71. Epub
2014 Dec 10.
8.
Wang Y, Liu G, Canfield MA, Mai CT, Gilboa SM, Meyer RE, Anderka M, Copeland GE,
Kucik JE, Nembhard WN, Kirby RS and the National Birth Defects Prevention Study.
Racial/Ethnic differences in survival of United States children with birth defects: a populationbased study. J Pediatr. 2015 April; 166(4):819-826.
Updated March 31, 2015
1
2014
9.
Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, Hobbs CA, Correa A, Honein MA,
and the National Birth Defects Prevention Study. Prenatal diagnosis of nonsyndromic
congenital heart defects. Prenatal Diagnosis. 2014; 34(3):214-222. Epub 2013 Dec 17.
10.
Botto LD, Panichello JD, Browne ML, Krikov MS, Feldkamp ML, Lammer E, Shaw GM and
the National Birth Defects Prevention Study. Congenital heart defects after maternal fever. Am
J Obstet Gynecol. 2014 April; 210(4):359.e1-359.e11. Epub 2013 Nov 1.
11.
Browne M, VanZutphen A, Botto L, Louik C, Richardson S, Druschel C. Maternal butalbital
use and selected defects in the National Birth Defects Prevention Study. Headache.
2014:54(1):54-66. Epub 2013 Sep 3.
12.
Carmichael SL, Ma C, Tinker S, Rasmussen SA, Shaw GM and the National Birth Defects
Prevention Study. Maternal Stressors and Social Support as Risks for Delivering Babies with
Structural Birth Defects. Paediatric and Perinatal Epidemiology. 2014 Jul;28(4):338-44.
Epub 2014 April 4.
13.
Case AP, Royle M, Scheuerle AE, Carmichael SL, Moffitt K, Ramadhani T, and the National
Birth Defects Prevention Study. Birth Defects, Causal Attributions, and Ethnicity in the
National Birth Defects Prevention Study. J Genet Counsel. 2014 Oct;23(5):860-73.
14.
Caspers Conway KM, Romitti PA, Holmes L, Olney RS, Richardson SD, the National Birth
Defects Prevention Study. Maternal periconceptional alcohol consumption and congenital limb
deficiencies. Birth Defects Res A Clin Mol Teratol. 2014 Aug 18. [Epub ahead of print]
15.
Chen L, Bell EM, Browne ML, Druschel CM, Romitti PA and the National Birth Defects
Prevention Study. Exploring maternal patterns of dietary caffeine consumption before
conception and during pregnancy. Matern Child Health J. 2014 Dec;18(10):2446-55.
16.
Dawson AL, Riehle-Colarusso T, Reefhuis J, Arena JF, and the National Birth Defects
Prevention Study. Maternal Exposure to Methotrexate and Birth Defects: A Population-Based
Study. Am J Med Genet Part A. 2014 Sep;164A(9):221206.
17.
Dawson AL, Tinker SC, Jamieson DJ, Hobbs CA, Rasmussen SA, Reefhuis J and the National
Birth Defects Prevention Study. Epidemiology of twinning in the National Birth Defects
Prevention Study, 1997 to 2007. Res A Clin Mol Teratol. 2014 Oct 31.
18.
Feldkamp ML, Kirkov S, Botto LD, Shaw GM, Carmichael SL and the National Birth Defects
Prevention Study. Better Diet Quality before Pregnancy Is Associated with Reduced Risk of
Gastroschisis in Hispanic Women. J Nutr. 2014 Nov;144(11):1781-6.
19.
Feldkamp ML, Srisukhumbowornchai S, Romitti PA, Olney RS, Richardson SD, Botto LD;
National Birth Defects Prevention Study. Self-reported maternal cigarette smoke exposure
during the periconceptional period and the risk for omphalocoele. Paediatr Perinat Epidemiol.
2014 Jan;28(1):67-73. Epub 2013 Nov 8.
Updated March 31, 2015
2
20.
Gilboa SM, Lee KA, Cogswell ME, Traven FK, Botto LD, Riehle-Colarusso T, Correa A,
Boyle CA, and the National Birth Defects Prevention Study. Maternal Intake of Vitamin E and
Birth Defects, National Birth Defects Prevention Study, 1997 to 2005. Birth Defects Res A Clin
Mol Teratol. 2014 Sep;100(9):647-57.
21.
Glidewell J, Reefhuis J, Rasmussen SA, Woomert A, Hobbs C, Romitti PA, Crider KS. Factors
affecting maternal participation in the genetic component of the NBDPS — United States,
1997-2007. Genet Med. 2014 Apr;16(4):329-37. Epub 2013 Sep 26.
22.
Hobbs CA, Cleves MA, MacLeod SL, Erickson SW, Tang X, Li J, Li M, Nick M, Malik S, and
the National Birth Defects Prevention Study. Conotruncal Heart Defects and Common Variants
in Maternal and Fetal Genes in Folate, Homocysteine, and Transsulfuration Pathways. Birth
Defects Res A Clin Mol Teratol. 2014 Feb:100(2):116-26.
23.
Hoyt AT, Browne M, Richardson S, Romitti P, Drushcel C and The National Birth Defects
Prevention Study. Maternal Caffeine Consumption and Small for Gestational Age Births:
Results from a Population-Based Case-Control Study. Matern Child Health J. 2014
Aug;18(6):1540-51. Epub 2013 Nov. 28.
24.
Hoyt AT, Canfield MA, Shaw GM, Waller DK, Polen KN, Ramadhani T, Anderka MT,
Scheuerle AE, the National Birth Defects Prevention Study. Sociodemographic acculturation
factors and isolated anotia/microtia. Birth Defects Res A Clin Mol Teratol. 2014 July 30.
[Epub ahead of print]
25.
Jenkins MM, Reefhuis J, Gallagher ML, Mulle JG, Hoffmann TJ, Koontz DA, Sturchio C,
Rasmussen SA, Witte JS, Richter P, Honein MA, and the National Birth Defects Prevention
Study. Maternal Smoking, Xenobiotic Metabolizing Enzyme Gene Variants, and Gastroschisis
Risk. Am J Med Genet Part A. 2014; 9999:1-10.
26.
Kancherla V, Romitti PA, Sun L, Carey JC, Burns TL, Siega-Riz AM, Druschel CM, Lin AE,
Olney RS, National Birth Defects Prevention Study. Descriptive and risk factor analysis of
choanal atresia: The National Birth Defects Prevention Study, 1997-2007. Eur J Med Genet.
2014 Apr;57(5):220-9. Epub 2014 Feb 24.
27.
Khodr ZG, Lupo PJ, Agopian AJ, Canfield MA, Case AP, Carmichael SL, Mitchell LE.
Preconceptional Folic Acid-Containing Supplement Use in the National Birth Defects
Prevention Study. Birth Defects Res A Clin Mol Teratol. 2014 Jun;100(6):472-82. Epub 2014
April 7.
28.
Kielb C, Lin S, Herdt-Losavio M, Bell E, Chapman B, Rocheleau CM, Lawson C, Waters M,
Stewart P, Olney RS, Romitti PA, Cao Y, Druschel C, & the National Birth Defects
Prevention Study. Maternal periconceptional occupational exposure to pesticides and selected
musculoskeletal birth defects. Int J Hyg Environ Health. 2014 Mar;217(2-3):248-54.
Epub 2013 Jun 20.
29.
Langlois PH, Hoyt AT, Desrosiers TA, Lupo PJ, Lawson CC, Waters MA, Rocheleau CM,
Shaw GM, Romitti PA, Gilboa SM, Malik S, and the National Birth Defects Prevention Study.
Maternal occupational exposures to polycyclic aromatic hydrocarbons and small for gestational
age offspring. Occup Environ Med. 2014 Aug;71(8):529-35. Epub 2014 June 3.
Updated March 31, 2015
3
30.
Li M, Cleves MA, Mallick H, Erickson SW, Tang X, Nick TG, Macleod SL, Hobbs CA, and
the National Birth Defects Prevention Study. A genetic association study detects haplotypes
associated with obstructive heart defects. Hum Genet. 2014 Sep;133(9):1127-38. Epub 2014
June 4.
31.
Li M, Erickson SW, Hobbs CA, Li Jingyuan, Tang X, Nick TG, Macleod SL, Cleves MA and
the National Birth Defects Prevention Study. Detecting Maternal-Fetal Genotypes Interactions
Associated With Conotruncal Heart Defects: A Haplotype-Based Analysis With Penalized
Logistic Regression. Genetic Epidemiology. 2014 Apr; 38(3):198-208. Epub 2014 Mar 2.
32.
Liberman RF, Stern JE, Luke B, Reefhuis J, Anderka M. Validating Assisted Reproductive
Technology Self-Report. Epidemiology. 2014 September;25(5):773-4.
33.
Lin AE, Krikov S, Riehle-Colarusso T, Frias JL, Belmont J, Anderka M, Geva T, Getz KD,
Botto LD, and the National Birth Defects Prevention Study. Laterality Defects in the National
Birth Defects Prevention Study (1998-2007): Birth Prevalence and Descriptive Epidemiology.
Am J Med Genet A. 2014 Aug 6; 9999:1–11.
34.
Lupo PJ, Mitchell LE, Canfield MA, Shaw GM, Olshan AF, Finnell RH, Zhu H and the
National Birth Defects Prevention Study. Maternal-fetal metabolic gene-gene interactions and
risk of neural tube defects. Mol Genet Metab. 2014 Jan;111(1):46-51. Epub 2013 Nov 18.
35.
Makelarski JA, Romitti PA, Rocheleau CM, Burns TL, Stewart PA, Waters MA, Lawson CC,
Bell EM, Lin S, Shaw GM, Olney RS; the National Birth Defects Prevention Study. Maternal
periconceptional occupational pesticide exposure and neural tube defects. Birth Defects Res A
Clin Mol Teratol. 2014 Aug 15. [Epub ahead of print]
36.
Miguel-Verges F, Mosley BS, Block AS, Hobbs CA. A spectrum project: preterm birth and
small-for-gestational age among infants with birth defects. J Perinatol. 2014 Oct 2. [Epub ahead
of print]
37.
Peterson C, Ailes E, Riehle-Colarusso T, Oster ME, Olney RS, Cassell CH, Fixler DE,
Carmichael SL, Shaw GM, Gilboa SM. Late Detection of Critical Congenital Heart Disease
Among US Infants: Estimation of the Potential Impact of Proposed Universal Screening Using
Pulse Oximetry. JAMA Pediatr. 2014 April;168(4):361-370.
38.
Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM, Shaw GM,
Carmichael SL. Costicosteroid Uses and Risk of Orofacial Clefts. Birth Defects Res A Clin
Mol Teratol. 2014 June;100(6):499-506. Epub 2014 Apr 29.
39.
Stingone JA, Luben TJ, Daniels JL, Fuentes M, Richardson DB, Aylsworth AS, Herring AH,
Anderka M, Botto L, Correa A, Gilboa SM, Langlois PH, Mosley B, Shaw GM, Siffel C,
Olshan AF, and the National Birth Defects Prevention Study. Maternal Exposure to Criteria Air
Pollutants and Congenital Heart Defects in Offspring: Results from the National Birth Defects
Prevention Study. Environ Health Perspect. 2014 Aug;122(8):863-72. Epub 2014 Apr 9.
Updated March 31, 2015
4
40.
Tang X, Nick TG, Cleves MA, Erickson SW, Li M, Li J, MacLeod SL, Hobbs CA. Maternal
obesity and tobacco use modify the impact of genetic variants on the occurrence of conotruncal
heart defects. PLos One. 2014 Oct 2;9(9).
41.
van Gelder MM, Donders AR, Devine O, Roeleveld N, Reefhuis J; National Birth Defects
Prevention Study. Using Bayesian Models to Assess the Effects of Under-reporting of Cannabis
Use on the Association with Birth Defects, National Birth Defects Prevention Study, 19972005. Paediatr Perinat Epidemiol. 2014 Sep;28(5):424-33. Epub 2014 Aug 26.
42.
Van Zutphen AR, Werler MM, Browne MM, Romitti PA, Bell EM, McNutt LA, Druschel CM,
Mitchell AA, for the National Birth Defects Prevention Study. Maternal Hypertension,
Medication Use, and Hypospadias in the National Birth Defects Prevention Study. Obstet
Gynecol. 2014;123:309-17.
43.
Weedn AE, Mosley BS, Cleves MA, Waller DK, Canfield MA, Correa A, Hobbs CA and the
National Birth Defects Prevention Study. Maternal reporting of prenatal ultrasounds among
women in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol.
2014;100(1):4-12. Epub 2013 Oct 5.
44.
Weyer PJ, Brender JD, Romitti PA, Kantamneni JR, Crawford D, Sharkey JR, Shinde M, Horel
SA, Vuong AM, Langlois PH. Assessing bottled water nitrate concentrations to evaluate total
drinking water nitrate exposure and risk of birth defects. J Water Health. 2014 Dec;12(4):75562.
45.
Woud SG, van Rooji IA, van Gelder MM, Olney RS, Carmichael SL, Roeleveld N, Reefhuis J,
National Birth Defects Prevention Study. Differences in risk factors for second and third degree
hypospadias in the national birth defects prevention study. Birth Defects Res A Clin Mol
Teratol. 2014 Sep;100(9):703-11. Epub 2014 Sep 2.
46.
Yang W, Carmichael SL, Roberts EM, Kegley SE, Padula AM, English PB, Shaw GM.
Residential Agricultural Pesticide Exposures and Risk of Neural Tube Defects and Orofacial
Clefts Among Offspring in the San Joaquin Valley of California. American Journal of
Epidemiology. 2014 March 15; 179(6):740-748. Epub 2014 Feb 18.
2013
47.
Agopian AJ, Waller DK, Lupo PJ, Canfield MA, Mitchell LE. A case-control study of maternal
bathing habits and risk for birth defects in offspring. Environ Health. 2013 Oct 16;12(1):88.
48.
Agopian, A. J., Tinker, S. C., Lupo, P. J., Canfield, M. A., Mitchell, L. E. Proportion of neural
tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol. 97(1):4246.
49.
Agopian AJ, Lupo PL, Canfield MA, Mitchell LE and the National Birth Defects Prevention
Study. Swimming pool use and birth defect risk. American Journal of Obstetrics and
Gynecology. 2013 Sep;209(3):219.e1-9. Epub 2013 Apr 27.
Updated March 31, 2015
5
50.
Ahrens KA, Anderka MT, Feldkamp ML, Canfield MA, Mitchell AA, Werler MM, & the
National Birth Defects Prevention Study. Antiherpetic medication use and the risk of
gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007.
Paediatric and Perinatal Epidemiology. 2013 Jul;27:340-345. Epub 2013 Jun 3.
51.
Brender JD, Weyer PJ, Romitti PA, Mohanty BP, Shinde MU, Vuong AM, Sharkey JR,
Dwivedi D, Horel SA, Kantamneni J, Huber JC Jr., Zheng Q, Werler MM, Kelley KE,
Griesenbeck JS, Zhan FB, Langlois PH, Suarez L, Canfield MA and the National Birth Defects
Prevention Study. Prenatal nitrate intake from drinking water and selected birth defects in
offspring of participants in the national birth defects prevention study. Environ Health
Perspect. 2013 Sep;121(9):1083-9. Epub 2013 Jun 11.
52.
Carmichael SL, Cogswell ME, Ma C, Gonzalez-Feliciano A, Olney RS, Correa A, Shaw GM
and the National Birth Defects Prevention Study. Hypospadias and maternal intake of
phytoestrogens. Am J Epidemiol. 2013 Aug 1;178(3):434-40. Epub 2013 Jun 9.
53.
Carmichael SL, Yang W, Shaw GM and the National Birth Defects Prevention Study. Maternal
dietary nutrient intake and risk of preterm delivery. Am J Perinatol. 2013 Aug;30(7):579-88.
Epub 2012 Dec 3.
54.
Caspers KM, Romitti PA, Lin S, Olney RS, Holmes LB, Werler MM, & National Birth Defects
Prevention Study. Maternal periconceptional exposure to cigarette smoking and limb
deficiencies. Paediatr Perinat Epidemiol. 2013 Nov;27(6):509-20.
55.
Huber JC, Brender JD, Zheng Q, Sharkey JR, Vuong AM, Shinde MU, Griesenbeck JS, Suarez
L, Langlois P, Canfield MA, Romitti PA, Weyer PJ and the National Birth Defects Prevention
Study. Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in
offspring: a case-control study. Nutrition Journal. 2013 March 21; 12:34.
56.
Khodr ZG, Lupo PJ, Canfield MA, Chan W, Cai Y, Mitchell LE. Hispanic ethnicity and
acculturation, maternal age and the risk of gastroschisis in the National Birth Defects
Prevention Study. Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):538-45. Epub 2013
Jun 3.
57.
Langlois PH, Hoyt AT, Lupo PJ, Lawson CC, Waters MA, Desrosiers TA, Shaw GM, Romitti
PA, Lammer EJ; Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk
of oral cleft-affected pregnancies. Cleft Palate Craniofac J. 2013. 50(3):337-46. Epub 2012
Nov 8.
58.
Lin S, Herdt-Losavio ML, Chapman BR, Munsie JP, Olshan AF, Druschel CM, & the National
Birth Defects Prevention Study. Maternal occupation and the risk of major birth defects: A
follow-up analysis from the National Birth Defects Prevention Study. Int J Hyg Environ
Health. 2013 June; 216(2): 317-324. Epub 2012 Jun 12.
59.
Lind, JN, Tinker, SC., Broussard, CS., Reefhuis, J., Carmichael, SL., Honein, MA., Olney, RS.,
Parker, SE., Werler, MM. Maternal medication and herbal use and risk for hypospadias: data
from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf.
2013 Jul;22(7):783-93. Epub 2013 Apr 26.
60.
Makelarski JA, Romitti PA, Sun L, Burns TL, Druschel CM, Suarez L, Olshan AF, Siega-Riz
AM, Olney RS; and the National Birth Defects Prevention Study. Periconceptional maternal
Updated March 31, 2015
6
alcohol consumption and neural tube defects. Birth Defects Res A Clin Mol Teratol 2013.
97(3):152-160.
61.
Polen K, Rasmussen SA, Riehle-Colarusso T, Reefhuis J, & National Birth Defects Prevention
Study. Association between reported venlafazine use in early pregnancy and birth defects,
National Birth Defects Prevention Study, 1997-2007. Birth Defects Res A Clin Mol Teratol
2013. 97(1):28-35.
62.
Shinde MU, Brender JD, Werler MM, Vuong AM, Kelley KE, Huber Jr. JC, Sharkey JR,
Griesenbeck JS, Romitti PA, Malik S, Suarez L, Langlois PH Canfield MA, & National Birth
Defects Prevention Study. Prenatal exposure to nitrosatable drugs, vitamin C and risk of
selected birth defects. Birth Defects Res A Clin Mol Teratol . Epub May 28 2013.
63.
Sotres-Alvarez, D., Siega-Riz, AM., Herring, AH., Carmichael, SL., Feldkamp, ML., Hobbs,
CA., Olshan, AF., and the National Birth Defects Prevention Study. Maternal Dietary Patterns
are Associated With Risk of Neural Tube and Congenital Heart Defects. Am J Epidemiol. 2013
Jun 1;177(11):1279-88. Epub 2013 May 2.
64.
Thorpe, PG, Gilboa SM, Hernandez-Diaz S, Lind J, Cragan JD, Briggs G, Kweder S, Friedman
JM, Mitchell AA, Honein MA. Medications in the first trimester of pregnancy: most common
exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf. 2013
Sep;22(9):1013-8. Epub 2013 Jul 29.
65.
Tinker, SC, Gibbs, C., Strickland, MJ, Devine, OJ, Crider, KS, Werler, MM, Anderka, MT,
Reefhuis, J., the National Birth Defects Prevention Study. Impact of Time to Maternal
Interview on Interview Responses in the National Birth Defects Prevention Study. Am J
Epidemiol. 2013 Jun 1;177(11):1225-35. Epub 2013 May 3.
66.
Van Bennekom CM, Mitchell AA, Moore CA, Werler MM and the National Birth Defects
Prevention Study. Vasoactive Exposures during Pregnancy and Risk of Microtia. Birth Defects
Res A Clin Mol Teratol. 2013 Jan;97(1):53-9. Epub 2012 Nov 24.
2012
67.
Agopian AJ, Lupo PJ, Herdt-Losavio ML, Langlois PH, Rocheleau CM, Mitchell LE, & The
National Birth Defects Prevention, S. Differences in folic acid use, prenatal care, smoking, and
drinking in early pregnancy by occupation. Prev Med 2012. 55(4): 341-345.
68.
Agopian AJ, Lupo PJ, Tinker SC, Canfield MA, Mitchell LE, & the National Birth Defects
Prevention Study. Working Towards a Risk Prediction Model for Neural Tube Defects. Birth
Defects Res A Clin Mol Teratol 2012. 94(3):141-6.
69.
Agopian A, CanfieldM, Olney R, Lupo P, Ramadhani T, Mitchell L, Shaw G, Moore C, and the
National Birth Defects Prevention Study. Spina bifida subtypes and sub-phenotypes by
maternal race/ethnicity in the National Birth Defects Prevention Study. Am J Med Genet A.
2012 Jan;158A(1):109-15. Epub 2011 Dec 2.
70.
Anderka M, Mitchell AA, Louik C, Werler MM, Hernandez-Diaz S, Rasmussen SA, &National
Birth Defects Prevention Study. Medications used to treat nausea and vomiting of pregnancy
and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 2012. 94(1): 22-30.
Epub 2011 Nov 19.
Updated March 31, 2015
7
71.
Brender JD, Werler MM, Shinde MU, Vuong AM, Kelley KE, Huber Jr. JC, Sharkey JR,
Griesenbeck JS, Romitti PA, Malik S, Suarez L, Langlois PH, Canfield MA; and the National
Birth Defects Prevention Study. Nitrosatable drug exposure during the first trimester of
pregnancy and selected congenital malformations. Birth Defects Res A Clin Mol Teratol 2012.
94(9):701-713.
72.
Carmichael SL, Ma C, Feldkamp ML, Munger RG, Olney RS, Botto LD, Shaw MG, Correa A
Nutritional factors and hypospadias risks. Paediatr Perinat Epidemiol 2012. 26(4): 353-360.
73.
Carmichael SL,Yang W, Feldkamp ML, Munger RG, Siega-Riz AM, Botto LD, and the
National Birth Defects Prevention Study. Reduced Risks of Neural Tube Defects and Orofacial
Clefts with Higher Diet Quality. Arch Pediatr Adolesc Med 2012. 166(2): 121-126. Epub 2011
Oct 3.
74.
Chandler AL, Hobbs CA, Mosley BS, Berry RJ, Canfield MA, Qi YP, Siega-Riz AM, Shaw G
& the National Birth Defects Prevention Study. Neural tube defects and maternal intake of
micronutrients related to one-carbon metabolism or antioxidant activity. Birth Defects Res A
Clin Mol Teratol 2012 Nov; 94:864-74.
75.
Chen L, Bell EM, Browne ML, Druschel CM, Romitti PA, Schmidt RJ, & the National Birth
Defects Prevention Study. Maternal caffeine consumption and risk of congenital limb
deficiencies. Birth Defects Res A Clin Mol Teratol 2012.
76.
Correa A, Gilboa S, Botto L, Moore C, Hobbs C, Cleves M, Colarusso-Riehle T, Waller K,
Reece A, & the National Birth Defects Prevention Study. Lack of periconceptional vitamins or
supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet
Gynecol 2012;206(3):218.e1-218.e13.
77.
Desrosiers TA, Herring AH, Shapira SK, Hooiveld M, Luben TJ, Herdt-Losavio ML, Lin S,
Olshan AF, and the National Birth Defects Prevention Study. Paternal occupation and birth
defects: findings from the National Birth Defects Prevention Study. Occup Environ Med 2012.
Aug;69(8): 534-542. Epub 2012 Jul 9.
78.
Desrosiers TA, Lawson CC, Meyer RE, Richardson DB, Daniels JL, Waters MA, van
Wijngaarden E, Langlois PH, Romitti PA, Correa A, Olshan AF, & the National Birth Defects
Prevention Study. Maternal occupational exposure to organic solvents during early pregnancy
and risks of neural tube defects and orofacial clefts. Occup Environ Med 2012. 69(7): 493-499.
EPub 2012 Mar 23.
79.
Desrosiers TA, Lawson CC, Meyer RE, Waters MA, van Wigngaarden E, Langlois PH, Romitti
PA, Correa A, Olshan AF. Re: The study of the relation between maternal occupational
exposure to solvents and birth defects should include oxygenated solvents (authors’ response).
Occup Environ Med 2012. 69(12):933-4. Epub 2012 Oct 9.
80.
Duong HT, Hoyt AT, Carmichael SL, Gilboa SM, Canfield MA, Case AP, McNeese ML,
Waller DK, & the National Birth Defects Prevention Study. (2012). Is maternal parity an
independent risk factor for birth defects? Birth Defects Res A Clin Mol Teratol 2012. 94(4):
230-236.
81.
Getz KD, Anderka MT, Werler MM, & Case AP. (2012). Short interpregnancy interval and
gastroschisis risk in the national birth defects prevention study. Birth Defects Res A Clin Mol
Teratol 2012. 94(9):714-20.
82.
Gilboa SM, Desrosiers TA, Lawson C, Lupo PJ, Riehle-Colarusso TJ, Stewart PA, van
Wijngaarden E, Waters MA, Correa A, and the National Birth Defects Prevention Study.
(2012). Association between maternal occupational exposure to organic solvents and congenital
Updated March 31, 2015
8
heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med 2012.
69(9): 628-635.
83.
Gill SK, Broussard C, Devine O, Green RF, Rasmussen SA, Reefhuis J, & and the National
Birth Defects Prevention, S. (2012). Association between maternal age and birth defects of
unknown etiology - United States, 1997-2007. Birth Defects Res A Clin Mol Teratol
2012;94(12):1010-1018.
84.
Hernandez RK, Werler MM, Romitti P, Sun L, Anderka M, and National Birth Defects
Prevention Study. Nonsteroidal antiinflammatory drug use among women and the risk of birth
defects. Am J Obstet Gynecol 2012. 206(3): 228 e221-228.
85.
Langlois PH, Hoyt AT, Lupo PJ, Lawson CC, Waters MA, Desrosiers TA, Shaw GM, Romitti
PA Lammer EJ, & the National Birth Defects Prevention Study. Maternal occupational
exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected
pregnancies. Birth Defects Res A Clin Mol Teratol, 2012. 94(9): 693-700
86.
Lin S, Munsie JP, Herdt-Losavio M, Druschel C, Campbell K, Browne M, Romitti P, Olney R,
Bell E and the National Birth Defects Prevention Study. Maternal asthma medication use and
the risk of selected birth defects. Pediatrics 2012. 129(2):e317-e324.
87.
Lupo PJ, Canfield MA, Chapa C, Lu W, Agopian AJ, Mitchell LE, Shaw GM, Waller DK,
Olshan AF, Finnell RH, Zhu H. Diabetes and Obesity-Related Genes and the Risk of Neural
Tube Defects in the National Birth Defects Prevention Study. Am J Epidemiol 2012.
176(12):1101-9.
88.
Lupo PJ, Chapa C, Nousome D, Duhon C, Canfield MA, Shaw GM, Finnell RH, Zhu H and the
National Birth Defects Prevention Study. (2012) A GCH1 Functional Haplotype and Risk of
Neural Tube Defects in the National Birth Defects Prevention Study. Mol Genet Metab 2012.
107(3):592-5.
89.
Lupo PJ, Langlois PH, Reefhuis J, Lawson CC, Symanski E, Desrosiers TA, Khodr ZG,
Agopian MA, Waters MA, Duwe KN, Finnell RH, Mitchell LE, Moore CA, Romitti PA, Shaw
GM, & the National Birth Defects Prevention Study. Maternal occupational exposure to
polycyclic aromatic hydrocarbons and the risk of gastroschisis in offspring. Environ Health
Perspec 2012. 120(6), 910-915.
90.
Lupo PJ, Symanski E, Langlois PH, Lawson CC, Malik S, Gilboa SM, Lee LJ, Agopian AJ,
Desrosiers TA, Waters MA, Romitti PA, Correa A, Shaw GM, Mitchell LE, and the National
Birth Defects Prevention Study. Maternal occupational exposure to polycyclic aromatic
hydrocarbons and congenital heart defects among offspring in the national birth defects
prevention study. Birth Defects Research Part A 2012. 94(11): 875-881.
91.
Ma C, Shaw GM, Scheuerle AE, Canfield MA, Carmichael SL, and National Birth Defects
Prevention Study. Association of microtia with maternal nutrition. Birth Defects Res A Clin
Mol Teratol 2012. 94(12):1026-32.
92.
Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, & National
Birth Defects Prevention Study. Use of topiramate in pregnancy and risk of oral clefts. Am J
Obstet Gyneco 2012. 207(5): 405.e1-405.e7
93.
Parker SE, Werler MM, Shaw GM, Anderka M, Yazdy MM, and the National Birth Defects
Prevention Study. Dietary glycemic index and the risk of birth defects. Am J Epidemiol 2012.
176(12):1110–20..
94.
Patel SS, Burns TL, Botto LD, Riehle-Colarusso TJ, Lin AE, Shaw GM, Romitti PA, and the
National Birth Defects Prevention Study. Analysis of selected maternal exposures and nonUpdated March 31, 2015
9
syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 19972005. Am J Med Genet A 2012. 158A:2447–245.
95.
Srisukhumboworchai S, Krikov S, Feldkamp ML. Self-reported maternal smoking during
pregnancy by source in Utah, 2003-2007. Birth Defects Res A Clin Mol Teratol. 2012
Dec;94(12):996-1003. Epub 2012 July 23.
96.
Yang W, Carmichael SL, Tinker SC, Shaw GM, & the National Birth Defects Prevention
Study. (2012). Association between weight gain during pregnancy and neural tube defects and
gastroschisis in offspring. Birth Defects Res A Clin Mol Teratol 2012. 94(12):1019-1025.
2011
97.
Alwan S, Reefhuis J, Rasmussen SA, Friedman JM, and the National Birth Defects Prevention
Study. Patterns of Antidepressant Medication Use Among Pregnant Women in a United States
Population. Journal of Clinical Pharmacology. 2011; 51:264-270. Epub 2010 Jul 27.
98.
Brender JD, Kelley KE, Werler MM, Langlois PH, Suarez L, Canfield MA, and the National
Birth Defects Prevention Study. Prevalence and patterns of nitrosatable drug use among U.S.
women during early pregnancy. Birth Defects Res A Clin Mol Teratol. 2011; 91(9):258-64.
99.
Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU, Zheng Q, Huber JC Jr, Sharkey
JR, Griesenbeck JS, Romitti PA, Langlois PH, Suarez L, Canfield MA, and the National Birth
Defects Prevention Study. Nitrosatable drug exposure during early pregnancy and neural tube
defects in offspring: the national birth defects prevention study. Am J Epidemiol. 2011;
174:1286-1295.
100.
Broussard C, Rasmussen S, Reefhuis J, Friedman J, Jann M, Colarusso-Riehle T, Honein M
and the National Birth Defects Prevention Study. Maternal Treatment with Opioid Analgesics
and Risk for Birth Defects. American Journal of Obstetrics and Gynecology. 2011;
204(4):314.e1-314.e11. Epub 2011 Feb 25.
101.
Browne ML, Hoyt AT, Feldkamp ML, Rasmussen SA, Marshall EG, Druschel CM, Romitti
PA. Maternal caffeine intake and risk of selected birth defects in the National Birth Defects
Prevention Study. Birth Defects Res A Clin Mol Teratol. 2011 Feb; 91(2):93-101.
102.
Carmichael SL, Gonzalez-Feliciano AG, Ma C, Shaw GM, Cogswell ME. Estimated dietary
phytoestrogen intake and major food sources among women during the year before pregnancy.
Nutr J. 2011 Oct; 10:105.
103.
Carter TC, Olney RS, Mitchell AA, Romitti PA, Bell EM, Druschel CM, and the National Birth
Defects Prevention Study. Maternal self-reported genital tract infections during pregnancy and
the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2011; 91(2):108-16.
Epub 2011 Feb 15.
104.
Cleves MA, Hobbs CA, Krakowiak PA, Zhao W, MacLeod SL and the National Birth Defects
Prevention Study. Assocation between selected folate pathway polymorphisms and
nonsyndromic limb reduction defects: a case-parental analysis. Paediatric and Perinatal
Epidemiology. 2011; 25(2):124-134. Epub 2011 Feb 2.
105.
Duong HT, Shahrukh Hashmi S, Ramadhani T, Canfield MA, Scheuerle A, Kim Waller D; the
National Birth Defects Prevention Study. Maternal use of hot tub and major structural birth
defects. Birth Defects Res A Clin Mol Teratol. 2011 Sep;91(9):836-41.
Updated March 31, 2015
10
106.
Feldkamp ML, Carmichael S, Shaw G, Panichello J, Botto L. Maternal nutrition and the risk of
gastroschisis: findings from the National Birth Defects Prevention Study. Am J Obstet Gynecol.
2011May; 204(5):404.e1-404.e10. Epub 2011 Mar 10.
107.
Gallagher M, Sturchio C, Smith A, Koontz D, Jenkins M, Honein M, Rasmussen S and the
National Birth Defects Prevention Study. Evaluation of mailed pediatric buccal cytobrushes for
use in a case-control study of birth defects. Birth Defects Res A Clin Mol Teratol. 2011 Jul;
91(7):642-8. Epub 2011 May 31.
108.
Hartman R, Colarusso-Riehle T, Lin A, Frias J, Patel S, Duwe K, Correa A, Rasmussen S and
the National Birth Defects Prevention Study. Descriptive study of non-syndromic
atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005. Am J
Med Genet A. 2011; 155A(3):555-64. Epub 2011 Feb 18.
109.
Jenkins MM, Reed-Gross E, Barfield WD, Prue CE, Gallagher ML, Rasmussen SA, Honein
MA. Qualitative assessment of study materials and communication strategies used in studies
that include DNA collection. Am J Med Genet Part A 2011; 155:2721-2731
110.
Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S; National Birth
Defects Prevention Study. Medication use during pregnancy, with particular focus on
prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011; 205(1):51.e1-51.e8.
111.
Munsie, J, Lin S, Campbell K, Caton A, Bell E, Browne M, Rasmussen S, Romitti P, Druschel
C and the National Birth Defects Prevention Study. Maternal Bronchodilator Use and the Risk
of Orofacial Clefts. Human Reproduction. 2011 Nov; 26(11):3147-3154.
112.
Olshan AF, Hobbs CA, Shaw GM. 2011. Discovery of genetic susceptibility factors for human
birth defects: an opportunity for a national agenda. American Journal of Medical Genetics Part
A, 2011; 155(8):1794–1797. [Epub 2011 Jul 7].
113.
Ramadhani TA, Canfield MA, Farag NH, Royle M, Correa A, Waller DK, Scheuerle A and the
National Birth Defects Prevention Study. Do foreign- and U.S.-born mothers across
racial/ethnic groups have similar risk profile for selected sociodemographic and
periconceptional factors? Birth Defects Res A Clin Mol Teratol. 2011 Sep; 91(9):823-30.
114.
Rasmussen SA, Riehle-Colarusso T, Shapira SK, Honein MA, Reefhuis J. Letter to the editor:
Ventricular septal defects and the National Birth Defects Prevention Study. BDRA. 2011;
91(1):66. Epub 2011 Jan 22.
115.
Reefhuis J, Honein M, Schieve L, Rasmussen S and the National Birth Defects Prevention
Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study,
1997-2005. Human Reproduction. 2011; 26(2):451-7. Epub 2010 Nov 26.
116.
Reefhuis J, Rasmussen SA, Honein MA and the National Birth Defects Prevention Study.
Prenatal versus postnatal repair of myelomeningocele. N Engl J Med, 2011;364(26):2555.
117.
Richardson S, Browne M, Rasmussen S, Druschel C, Sun L, Wang Jabs E, Romitti P and the
National Birth Defects Prevention Study. Associations between periconceptional alcohol
consumption and craniosynostosis, omphalocele, and gastroschisis. BDRA. 2011; 91(7):62330. Epub 2011 May 31.
118.
Rocheleau CM, Lawson CC, Waters MA, Hein MJ, Stewart PA, Correa A, Echeverria D,
Reefhuis J. Inter-rater reliability of assessed prenatal maternal occupational exposures to
solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occ Env Hyg, 2011; 8: 718728.
Updated March 31, 2015
11
119.
Rocheleau C, Romitti P, Sanderson W, Lawson T, Sun L, Waters M, Stewart P, Reefhuis J,
Olney R and the National Birth Defects Prevention Study. Maternal occupational pesticide
exposure and risk of hypospadias in the national birth defects prevention study. Birth Defects
Res A Clin Mol Teratol, 2011; 91: 927-936.
120.
Shaw GM, Carmichael SL, Yang W, Siega-Riz AM. Periconceptional intake of folic acid and
food folate and risks of preterm delivery. Am J Perinatol. 2011 Jun 16 (Dec);28(10):747-52.
121.
Suarez L, Canfield MA, Ramadhani T, Brender JD, Felkner M, Romitti P, Sun L, and the
National Birth Defects Prevention Study. Maternal smoking, passive tobacco smoke, and neural
tube defects. Birth Defects Res A Clin Mol Teratol, 2011; 91(1):29-33.
122.
Tinker S, Reefhuis J, Dellinger A, Jamieson D and the National Birth Defects Prevention
Study. Maternal injuries during the periconceptional period and the risk of birth defects,
National Birth Defects Prevention Study, 1997-2005, National Birth Defects Prevention Study,
1997-2005. Paediatr Perinat Epidemiol, 2011; 25(5):487-96.
123.
Toh S, Mitchell AA, Anderka M, de Jong-van den Berg LT, Hernandez-Diaz S. Antibiotics and
oral contraceptive failure-a case-crossover study. Contraception. 2011 May;83(5):418-25. Epub
2010 Oct 8.
124.
Werler MM, Ahrens KA, Bosco JL, Mitchell AA, Anderka MT, Gilboa SM, Holmes LB, and
the National Birth Defects Prevention Study. Use of antiepileptic medications in pregnancy in
relation to risks of birth defects. Annals of Epidemiology. 2011; 21(11):842-50.
2010
125.
Alwan S, Reefhuis J, Botto LD, Rasmussen SA, Correa A, Friedman JM, and the National
Birth Defects Prevention Study. Maternal use of bupropion and risk for congenital heart defects.
Am J Obstet Gynecol. 2010. 203:52 e.1-6. Epub 2010 Apr 22.
126.
Anderka M, Romitti PA, Sun L, Druschel C, Carmichael S, Shaw G and the National Birth
Defects Prevention Study. Patterns of tobacco exposure before and during pregnancy. Acta
Obstet Gynecol Scand. 2010;89(4):505-14.
127.
Boulet S, Rasmussen S, Honein M and the National Birth Defects Prevention Study. Maternal
Body Mass Index as a Risk Factor for Craniosynostosis. Am J Med Genet A. 2010;
152A(11):2895-7.
128.
Broussard CS, Louik CA, Honein MA, Mitchell AA, and the National Birth Defects Prevention
Study. Herbal use before and during pregnancy. Am J Obstet Gynecol. 2010. 202(5):443e1-6.
Epub 2009 Dec 29.
129.
Carmichael S, Rasmussen S, Lammer E, Chen M, Shaw G and the National Birth Defects
Prevention Study. Craniosynostosis and nutrient intake during pregnancy. Birth Defects Res A
Clin Mol Teratol. 2010; 88:1032-39. Epub 2010 Sep 14.
130.
Carmichael SL, Yang W, Shaw GM. Periconceptional nutrient intakes and risks of neural tube
defects in California. Birth Defects Res A Clin Mol Teratol. 2010 Aug;88(8):670-8.
131.
Caspers K, Oltean C, Romitti P, Sun L, Pober B, Rasmussen S, Yang W, Druschel C and the
National Birth Defects Prevention Study. Maternal periconceptional exposure to cigarette
smoking and alcohol consumption and congenital diaphragmatic hernia. Birth Defects Res Part
A Clin Mol Teratol. 2010; 88:1040-1049.
Updated March 31, 2015
12
132.
Dott M, Reefhuis J, Hogue CJ, Rasmussen SA. Association between pregnancy intention and
reproductive-health related behaviors before and after pregnancy recognition, National Birth
Defects Prevention Study, 1997-2002. Matern Child Health J. 2010; 14(3): 373-81. Epub 2009
Feb 28.
133.
Duwe, Reefhuis, Honein, Schieve, Rasmussen, and the National Birth Defects Prevention
Study. Epidemiology of fertility treatment use among US women with liveborn infants, 19972004. Journal of Women’s Health. 2010. 19(3): 407-416. Epub 2010 Feb 2.
134.
Feldkamp ML, Meyer RE, Krikov S, Botto LD. Acetaminophen use in pregnancy and risk for
birth defects: findings from the National Birth Defects Prevention Study. Ob Gyn. 2010;
115(1):109-15.
135.
Fisk Green R, Devine O, Crider KS, Olney RS, Archer N, Olshan AF, Shapira SK, and the
National Birth Defect Prevention Study. Association of Paternal Age and Risk for Major
Congenital Anomalies from the National Birth Defects Prevention Study, 1997-2004. Annals of
Epidemiology. 2010. 20(3):241-9. Epub 2010 Jan 6.
136.
Gilboa SM, Correa A, Botto LD, Rasmussen SA, Waller DK, Hobbs, CA, Cleves MA, RiehleColarusso TJ, and the National Birth Defects Prevention Study. Association between
prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol. 2010
Jan;202(1):51.
137.
Griesenbeck JS, Brender JD, Sharkey JR, Steck MD, Huber JC Jr, Rene AA, McDonald TJ,
Romitti PA, Canfield MA, Langlois PH, Suarez L, and the National Birth Defect Prevention
Study. Maternal characteristics associated with the dietary intake of nitrates, nitrites, and
nitrosamines in U.S. women of child-bearing age: a cross-sectional study. Environ Health. 2010
Feb 19;9:10-23.
138.
Hashmi SS, Galloway MS, Waller DK, Langlois P, Hecht JT and the National Birth Defects
Prevention Study. Maternal Fever during Early Pregnancy and the Risk of Oral Clefts. Birth
Defects Res Part A Clin Mol Teratol. 2010. 88(3):186-194.
139.
Herdt-Losavio ML, Lin S, Chapman BR, Hooiveld M, Olshan A, Liu X, DePersis RD, Zhu J,
Druschel CM and the National Birth Defects Prevention Study. Maternal occupation and the
risk of birth defects: An overview from the National Birth Defects Prevention Study.
Occupational and Environmental Medicine. 2010 Jan; 67(1):58-66.
140.
Lupo PJ, Symanski E, Waller DK, Chan W, Canfield MA, Langlois PH, Mitchell LE, and the
National Birth Defects Prevention Study. Polytomous Logistic Regression as a Tool for
Exploring Heterogeneity across Birth Defect Subtypes: An Example Using Anencephaly and
Spina Bifida. Birth Defects Res A Clin Mol Teratol, 2010; 88(8):701-705.
141.
Ma C, Carmichael SL, Scheuerle AE, Canfield MA, Shaw GM. Association of microtia with
maternal obesity and periconceptional folic acid use. Am J Med Genet A. 2010;152A(11):275661.
142.
Miller EA, Rasmussen SA, Siega-Riz AM, Frı´as JL, Honein MA, the NationalBirth Defects
Prevention Study. Risk factors for non-syndromic holoprosencephaly in the National Birth
Defects Prevention Study. Am J Med Genet Part C Semin Med Genet. 2010; 154C:62–72.
143.
Prakalapakorn SG, Rasmussen SA, Lambert SR, Honein MA, and the National Birth Defects
Prevention Study. Assessment of risk factors for infantile cataracts using a case-control study,
National Birth Defects Prevention Study, 2000-2004. Ophthalmology. 2010; 117(8):1500-1505.
Epub 2010 Apr 7.
Updated March 31, 2015
13
144.
Sanchez-Lara PA, Carmichael SL, Graham JM, Lammer EJ, Shaw GM, Ma C, Rasmussen
SA. Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Gen
2010(Feb);152A:394-400
145.
Schmidt R, Romitti P, Burns T, Murray J, Browne M, Druschel C, Olney R, and the National
Birth Defects Prevention Study. Caffeine, selected metabolic gene variants, and risk of neural
tube defects. Birth Defects Res A Clin Mol Teratol. 2010 Jul;88(7):560-9.
146.
Shaw GM, Carmichael SL, Yang W, Lammer EJ. Periconceptional nutrient intakes and risks of
conotruncal heart defects. Birth Defects Res A Clin Mol Teratol. 2010 March;88(3):144-51.
147.
Tinker S, Reefhuis J, Dellinger A, Jamieson D and the National Birth Defects Prevention
Study. Epidemiology of maternal injuries during pregnancy in a population-based study, 19972005. Journal of Women’s Health. 2010; 19(12):2211-8. Epub 2010 Nov 12.
148.
van Gelder MMHJ, Reefhuis J, Caton A, Werler M, Druschel C, Roeleveld N. Characteristics
of pregnant illicit drug users and the association cannabis and perinatal outcome in a
population-based study. Journal of Drug and Alcohol Dependence. 2010. 109(1-3): 243-247.
Epub Feb 23.
149.
Waller DK, Gallaway MS, Taylor LG, Ramadhani TA, Canfield MA, Scheuerle A, HernándezDíaz S, Louik C, Correa A, and the National Birth Defects Prevention Study. Use of oral
contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology. 2010
Mar;21(2):232-9.
2009
150.
Bird TM, Robbins JM, Druschel C, Cleves MA, Yang S, Hobbs CA, and the National Birth
Defects Prevention Study. Demographic and environmental risk factors for gastroschisis and
omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg. 2009; 44(8):154651.
151.
Browne ML, Rasmussen SA, Hoyt AT, Waller DK, Druschel CM, Caton AR, Canfield MA,
Lin AE, Carmichael SL, Romitti PA, and the National Birth Defects Prevention Study.
Maternal thyroid disease, thyroid medication use and selected birth defects in the National Birth
Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2009; 85(7):621-8.
152.
Canfield MA, Ramadhani TA, Shaw GM, Carmichael SL, Waller DK, Mosley BS, Royle MH,
Olney RS, and the National Birth Defects Prevention Study. Anencephaly and spina bifida
among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth
Defects Prevention Study. Birth Defects Research (Part A) Clinical and Molecular Teratology.
2009; 85:637-646.
153.
Carmichael SL, Ma C, Werler MM, Olney RS, Shaw GM, and the National Birth Defects
Prevention Study. Maternal corticosteroid use and hypospadias. J Pediatr. 2009 Jul;155(1):3944, 44.e1. Epub 2009 Apr 24.
154.
Carmichael SL, Yang W, Correa A, Olney RS, Shaw GM, for the National Birth Defects
Prevention Study. Hypospadias and intake of nutrients related to one-carbon metabolism.
Journal of Urology. 2009;181:315-321. Epub 2008 Nov 13.
155.
Caton, AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti
PA, Mitchell AA, Olney RS, Correa A and the National Birth Defects Prevention Study.
Antihypertensive medication use during pregnancy and the risk of cardiovascular
malformations. Hypertension. 2009; 54: 63-70. [2009 Top Paper in Population Science Award]
Updated March 31, 2015
14
156.
Cogswell ME, Bitsko RH, Anderka M, Caton AR, Feldkamp ML, Hockett-Sherlock SM,
Meyer RE, Ramadhani T, Robbins JM, Shaw G, Mathews TJ, Royle M, Reefhuis J and the
National Birth Defects Prevention Study. Control Selection and Participation in an Ongoing,
Population-Based, Case-Control Study of Birth Defects, the National Birth Defects Prevention
Study. Am. J. Epidemiol. 2009; 170: 975-985.
157.
Collier SA, Rasmussen SA, Feldkamp ML, Honein MA and the National Birth Defects
Prevention Study. Prevalence of self-reported infection during pregnancy among control
mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol.
2009 Mar;85(3):193-201.
158.
Collier SA, Browne ML, Rasmussen SA, Honein MA, and the National Birth Defects
Prevention Study. Maternal caffeine intake during pregnancy and orofacial clefts. Birth Defects
Res Part A Clin Mol Teratol 2009; 85:842-849.
159.
Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ and the National Birth Defects
Prevention Study. Antibacterial medication use during pregnancy and risk of birth defects:
National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009; 163(11): 978-85.
160.
Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM,
Romitti PA and the National Birth Defects Prevention Study. Alcohol consumption by women
before and during pregnancy. Maternal Child Health J. 2009. 13(2):274-85.
161.
Gallaway MS, Waller DK, Canfield MA, Scheuerle A and the National Birth Defects
Prevention Study. The association between use of spermicides or male condoms and major
structural birth defects. Contraception. 2009; 80(5): 422-9.
162.
Genisca AE, Frías JL, Broussard CS, Honein MA, Lammer EJ, Moore CA, Shaw GM, Murray
JC, Yang W, Rasmussen SA, and the National Birth Defects Prevention Study. Orofacial Clefts
in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A. 2009.
149A(6):1149-58.
163.
Gilboa SM, Strickland MJ, Olshan AF, Werler MW, Correa A, and the National Birth Defects
Prevention Study. Use of Antihistamine Medications During Early Pregnancy and Isolated
Major Malformations. Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):137-50.
164.
Griesenbeck JS, Steck MD, Huber JC, Sharkey JR, Rene AA, Brender JD. Development of
estimates of dietary nitrates, nitrites, and nitrosamines for use with the short Willet food
frequency questionnaire. Nutrition Journal, 2009; Apr 6;8:16
165.
Jenkins MM, Reed-Gross E, Rasmussen SA, Barfield WD, Prue CE, Gallagher ML, Honein
MA. Maternal attitudes toward DNA collection for gene–environment studies: A qualitative
research study. Am J Med Genet Part A 2009; 149A:2378–2386.
166.
Johnson CY, Honein MA, Hobbs CA, Rasmussen SA, and the National Birth Defects
Prevention Study. Prenatal diagnosis of orofacial clefts, National Birth Defects Prevention
Study, 1998-2004. Prenat Diagn. 2009 Sep;29(9):833-9.
167.
Langlois PH, Ramadhani T, Royle M, Robbins JM, Scheuerle AE, Wyzynski DF, and the
National Birth Defects Prevention Study. Birth defects and military service since 1990. Military
Medicine. 2009 Feb;174(2):170-6.
168.
Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C, and the National Birth Defects
Prevention Study. Maternal asthma, asthma medication use, and the risk of congenital heart
defects. Birth Defects Res A Clin Mol Teratol. 2009;85(2):161-8. Epub 2008 Dec 11.
Updated March 31, 2015
15
169.
MacLehose RF, Olshan AF, Herring AH, Honein MA, Shaw GM, Romitti PA, and the National
Birth Defects Prevention Study. Bayesian methods for correcting misclassification: An example
from birth defects epidemiology. Epidemiology, 2009 Jan: 20(1):27-35.
170.
Miller EA, Manning SE, Rasmussen SA, Reefhuis J, Honein MA. Maternal exposure to
tobacco smoke, alcohol and caffeine and risk of anorectal atresia – National Birth Defects
Prevention Study 1997-2003. Paediatr Perinat Epidemiol. 2009 Jan;23(1):9-17.
171.
Mosley BS, Cleves MA, Hobbs CA, Siega-Riz AM, Shaw GM, Zhao W, Canfield MA,
Wyszynski, Waller DK, and the National Birth Defects Prevention Study. Neural tube defects
and maternal folate intake among pregnancies conceived after folic acid fortification in the U.S.
Am J Epidemiol. 2009. 169(1):9-17.
172.
Ramadhani TR, Short V, Canfield MA, Waller DK, Kim Waller, Correa A, Royle MH,
Scheuerle A, and the National Birth Defects Prevention Study (NBDPS). Are birth defects
among Hispanics related to maternal nativity or number of years lived in the United States?
Birth Defects Part A Clin Mol Teratol. 2009 Sep;85(9):755-63
173.
Reefhuis J, Honein MA, Schieve LA, Correa A, Hobbs CA, Rasmussen SA, and the National
Birth Defects Prevention Study. Assisted reproductive technology and major structural birth
Hum Reprod. 2009; 24:360-6.
174.
Robitaille J, Carmichael SL, Shaw, GM, Olney RS. Maternal nutrient intake and risks for
transverse and longitudinal limb deficiencies: data from the National Birth Defects Prevention
Study, 1997-2003. National Birth Defects Prevention Study. Birth Defects Res Part A Clin Mol
Teratol. 2009 Sep;85(9):773-779.
175.
Schmidt RJ, Romitti PA, Burns TL, Murray JC, Druschel C, Browne M, Olney RS, and the
National Birth Defects Prevention Study. Maternal caffeine consumption and neural tube
defects. Birth Defects Res A Clin Mol Teratol. 2009. 85:879-89.
176.
Siega-Riz AM, Herring AH, Olshan AF, Smith J, Moore CA and the National Birth Defects
Prevention Study. The joint effects of maternal prepregnancy [pregravid] body mass index and
age on the risk of gastroschisis. Paediatr Perinat Epidemiol.2009 Jan;23(1):51-7.
177.
van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N, and the
National Birth Defects Prevention Study. Maternal Periconceptional Illicit Drug Use and the
Risk of Congenital Malformations. Epidemiology. 2009. 20:60-66.
178.
Werler MM, Bosco JLF, Shapira SK, and the National Birth Defects Prevention
Study. Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects.
Birth Defects Res A Clin Mol Teratol. 2009; 85:52-7.
179.
Werler MM, Mitchell AA, Moore CA, Honein MA, and the National Birth Defects Prevention
Study. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of
gastroschisis? Am J Med Genet A. 2009 Jul; 149A(7):1399-406
2008
180.
Bitsko R, Reefhuis J, Louik C, Werler MM, Feldkamp ML, Waller K, Frias J, Honein and the
National Birth Defects Prevention Study. Periconceptional Use of Weight loss Products
Including Ephedra and the Association with Birth Defects. Birth Defects Res A Clin Mol
Teratol 2008; 82(8): 553-62.
Updated March 31, 2015
16
181.
Carmichael SL, MA C, Rasmussen SA, Honein MA, Lammer EJ, Shaw GM and the National
Birth Defects Prevention Study. Craniosynostosis and maternal smoking. Birth Defects Res A
Clin Mol Teratol. 2008 Feb; 82(2):78-85
182.
Carter TC, Druschel CM, Romitti PA, Olney R, Werler M, Mitchell A and the National Birth
Defects Prevention Study. Antifungal drugs and the risk of selected birth defects. American
Journal of Obstetrics and Gynecology. 2008; 198(2):191.e1-191.e7
183.
Caton AR, Bell EM, Druschel CM, Werler MM, Mitchell AA, Browne ML, McNutt LA,
Romitti PA, Olney RS, Correa A, and the National Birth Defects Prevention Study. Maternal
hypertension, antihypertensive medication use and the risk of severe hypospadias. Birth Defects
Research Part A. 2008; 82:34-40.
184.
Cleves MA, Malik S, Yang S, Carter T, Hobbs CA, the National Birth Defects Prevention
Study. Maternal urinary tract infections and selected cardiovascular malformations. Birth
Defects Research (Part A) Clin Mol Teratol 2008; 82(6): 464-73.
185.
Correa A, Gilboa S, Besser LM, Botto L, Moore CA, Hobbs CA, Cleves M, Riehle T, Waller
K, Reece AE and the National Birth Defects Prevention Study. Diabetes mellitus and birth
defects. Am J Obstet Gynecol. 2008 Sep;199(3):237.e1-9.
186.
Feldkamp ML, Reefhuis J, Kucik J, Krikov S, Wilson A, Moore CA, Carey JC, Botto LD and
the National Birth Defects Prevention Study. Case-control study of self reported genitourinary
infections and risk of gastroschisis: findings from the national birth defects prevention study,
1997-2003. BMJ. 2008 Jun 21; 336(7658): 1420-3. Epub 2008 Jun 16.
187.
Fisk Green R, Olney RS, Reefhuis J, Botto LD, Romitti PA. Maternal reports of family history
from the National Birth Defects Prevention Study, 1997-2001 Genet Med 2008; 10(1): 37-45.
188.
Jenkins MM, Rasmussen SA, Moore CA, Honein MA; Ethical issues raised by incorporation of
genetics into the National Birth Defects Prevention Study. American Journal of Medical
Genetics. Part C, Seminars in Medical Genetics. 2008 Feb; 148C(1):40-6.
189.
Lin S, Munsie JP, Herdt-Losavio ML, Bell EM, Druschel C, Romitti PA, Olney RS, and the
National Birth Defects Prevention Study. Maternal asthma medication use and the risk of
gastroschisis. Am J Epidemiol. 2008; 168(1): 73-9.
190.
Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA and the National
Birth Defects Prevention Study. Maternal smoking and congenital heart defects. Pediatrics.
2008 ;121(4):e810-6.
191.
Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA, and the National
Birth Defects Prevention Study. Maternal Exposure to Statins and Risk for Birth Defects: A
Case-Series Approach (research letter). Am J Med Genet A. 2008 Oct 15;146A(20):2701-5.
192.
Shaw GM, Carmichael SL, Laurent C, Siega-Riz AM. Periconceptional glycemic load and
intake of sugars and their association with neural tube defects in offspring. Paediatr Perinat
Epidemiol 2008;22(6):514-9.
193. Slickers J, Olshan AF, Siega-Riz AM, Honein MA, Aylsworth AS and the National Birth
Defects Prevention Study. Maternal body mass index and lifestyle exposures and the risk of
bilateral renal agenesis or hypoplasia: Findings from the National Birth Defects Prevention
Study.Am J Epidemiol 2008 Dec 1; 168(11):1259-67. EPub2008 Oct 3.
194.
Wong-Gibbons DL, Romitt PA, Sun L, Moore CA, Reefhuis J, Bell EM, Olshan AF, and the
National Birth Defects Prevention Study. Maternal periconceptional exposure to cigarette
Updated March 31, 2015
17
smoking and alcohol and esophageal atresia +/- tracheo-esophageal fistula. Birth Defects Res A
Clin Mol Teratol. 2008; 82(11):776-84.
195.
Yang J, Carmichael SL, Canfield M, Song J, Shaw GM. Socioeconomic status in relation to
selected birth defects in a large multi-centered US case-control study. American Journal of
Epidemiology. 2008; 167(2):145-154.
196.
Yang W, Shaw GM, Carmichael SL, Rasmussen SA, Waller DK, Pober BR, Anderka M, and
the National Birth Defects Prevention Study. Nutrient intakes in women and congenital
diaphragmatic hernia in their offspring. Birth Defects Res A Clin Mol Teratol. 2008; 82(3): 1318.
2007
197.
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM for the National Birth Defects
Prevention Study. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of
birth defects. N Engl J Med 2007;356:2684-92.
198.
Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A and National Birth Defects
Prevention Study. Classifying and evaluating congenital heart defects in etiologic studies:
Experience from the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol
Teratol 2007; 79(10):714-27.
199.
Browne ML, Bell EM, Druschel CM, Gensburg LJ, Mitchell AA, Lin AE, Romitti PA, Correa
A, and the National Birth Defects Prevention Study. Maternal caffeine consumption and risk of
cardiovascular malformations. Birth Defects Res A Clin Mol Teratol 2007; 79(7):533-543.
200.
Carmichael SL, Shaw GM, Laurent C, Olney RS, Lammer EJ, and the National Birth Defects
Prevention Study. Maternal reproductive and demographic characteristics as risk factors for
hypospadias. Paediatric and Perinatal Epidemiology, 2007;21:210-218.
201.
Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal
corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007; 197:585.e1-585.e7.
202.
Honein M, Rasmussen SA, Reefhuis J, Romitti PA, Lammer E, Sun L, Correa A. Maternal
smoking and environmental tobacco smoke exposure and the risk of orofacial clefts, National
Birth Defects Prevention Study, 1997-2001. Epidemiology 2007; 18(2):226-33.
203.
Malik S, Cleves MA, Zhao W, Correa A, Hobbs CA. Association between congenital heart
defects and small for gestational age. Pediatrics. 2007; 119:e976-e982.
204.
Rasmussen SA, Yazdy MM, Carmichael SL, Jamieson DJ, Canfield MA, Honein MA, and the
National Birth Defects Prevention Study. Maternal thyroid disease as a risk factor for
craniosynostosis. Obstet Gynecol 2007; 110:369-77.
205.
Romitti PA, Sun L, Honein MA, Rasmussen SA, Correa A, Reefhuis J, and the National Birth
Defects Prevention Study. Maternal periconceptional alcohol consumption and risk of orofacial
clefts. Am J Epidemiol 2007. 166:775-785.
206.
Shaw GM, Carmichael SL, Laurent C, Louik C, Finnell RH, Lammer EJ and National Birth
Defects Prevention Study. Nutrient intakes in women and risks of anophthalmia and
microphthalmia in their offspring. Birth Defects Research Part A 2007; 79;708-713.
207.
The N, Honein MA, Caton AR, Moore C, Siega-Riz AM, Druschel CM. Risk factors for
isolated biliary atresia, National Birth Defects Study, 1997-2002. American Journal of Medical
Genetics. 2007 Oct; 143(19):2274-84.
Updated March 31, 2015
18
208.
Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Gallaway
MS, Correa A. Pre-pregnancy obesity: A risk factor for structural birth defects. Arch of Pediatr
Adolesc Med 2007;161:745-50.
2006
209.
Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle MH, Canfield M. National
Birth Defects Prevention Study. Correlates of intake of folic acid-containing supplements
among pregnant women. Am J Obstet Gynecol. 2006 Jan;194(1):203-10.
210.
Crider KS, Reefhuis J, Woomert A, Honein MA. Racial and ethnic disparity in participation in
DNA collection at the Atlanta site of the National Birth Defects Prevention Study. Am J
Epidemiol. 2006 Oct 15;164(8):805-12. Epub 2006 July 28.
211.
Reefhuis J, Rasmussen SA, Friedman JM. Selective serotonin reuptake inhibitors (SSRIs) and
persistent pulmonary hypertension of the newborn [letter] N Engl J Med 354:2188-2189, 2006.
212.
Shaw GM, Carmichael SL, Laurent C, Rasmussen SA. Maternal nutrient intakes and risks of
orofacial clefts. Epidemiology 2006; 17:285-291.
213.
Siega-Riz AM, Olshan AF, Werler MM, Moore C. Fat intake and the risk of gastroschisis. Birth
Defects Res A Clin Mol Teratol 2006; 76(4):241-5. Epub 2006 Apr 1. PMID16575898.
2005
214.
Carmichael SL, Shaw GM, Laurent C, Lammer EJ, Olney RS, and the National Birth Defects
Prevention Study. Hypospadias and maternal exposures to cigarette smoke. Paediatric and
Perinat Epidemiol.2005; 19(5):333-404.
215.
Carmichael SL, Shaw GM, Laurent C, Croughan MS, Olney RS, Lammer EJ. Maternal
progestin intake and risk of hypospadias. Archives of Pediatrics & Adolescent Medicine. 2005;
159:957-962.
216.
Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter
medications during pregnancy. American Journal of Obstetrics and Gynecology. 2005;
193:771-7.
2004
217.
Centers for Disease Control and Prevention. Evaluation of an Association between Loratadine
and Hypospadias. Morbidity and Mortality Weekly Report (MMWR). 2004; 53(10):219-221.
218.
Cleves MA, Savell Jr VH., Raj S, Zhao W, Correa A, Werler MM, Hobbs CA. Maternal use of
acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular
septal defects. Birth Defects Research (Part A) Clin Mol Teratol. 2004; 70:107-113.
2003
219.
Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, and the
National Birth Defects Prevention Study. Guidelines for case classification for the National
Birth Defects Prevention Study. Birth Defects Research Part A. 2003; 67(3):193-201.
Updated March 31, 2015
19
2002
220.
Rasmussen SA, Lammer EJ, Shaw GM, Finnell RH, McGehee RE, Gallagher M, Romitti PA,
Murray JC and the National Birth Defects Prevention Study. Integration of DNA sample
collection into a multi-site birth defects case-control study. Teratology. 2002; 66:177-84.
2001
221.
Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P,
Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. The National Birth Defects
Prevention Study. Public Health Reports. 2001; 116:32-40.
Updated March 31, 2015
20
Published Abstracts/Presentations
2014
1.
Lim H, Agopian AJ, Whitehead LW, Beasley CW, Langlois PH, Emery RJ, Waller DK and the
National Birth Defects Prevention Study. 0306 Parental occupational exposure to ionizing radiation
and selected birth defects in the US. Occup Environ Med. 2014;71:A105.
2013
2.
Agopian AJ, Lupo PJ, Canfield MA, Mitchell LE; National Birth Defects Prevention
Study. Maternal Use of Swimming Pools and Risk for Birth Defects in Offspring, National Birth
Defects Prevention Network and National Birth Defects Prevention Study Annual
Meeting. Atlanta, GA, Feb 2013.
3.
Botto LD: Maternal diet quality and risk for congenital heart defects. Presented at the
40thInternational Clearinghouse for Birth Defects Surveillance and Research, San Jose, Costa Rica.
Dec 5, 2013.
4.
Browne M, Van Zutphen A, Richardson S, Druschel D, Blossom S, Broussard C, Carmichael S.
Maternal autoimmune disease and selected defects in the National Birth Defects Prevention Study.
Poster presented at the joint National Birth Defects Prevention Network/National Birth Defects
Prevention Study 2013 Annual Meeting, Atlanta, GA, February 25-27, 2013.
5.
Case A, Hoyt AT, Canfield MA, Wilkinson A. Periconceptional Risk Factors among Younger
and Older Teens. Poster presented at the Combined Annual Meeting of the National Birth Defects
Prevention Network and the National Birth Defects Prevention Study, Atlanta, GA, February 25-27,
2013.
6.
Duwe KN, Alverson CJ, Callaghan W, Canfield MA, Correa A, Duke CW, Marshall E, Olney R,
Reefhuis J, Romitti P, Gilboa S. Association between previous fetal loss and birth defects, National
Birth Defects Prevention Study (NBDPS), 1997-2007. Presented at the Combined Annual Meeting
of the National Birth Defects Prevention Network and the National Birth Defects Prevention Study,
Atlanta, GA, February 25-27, 2013.
7.
Feldkamp ML: Critical Congenital Heart Defects Screening: Birth Defects and Newborn Screening
Program Interactions. Presented at the 16th National Birth Defects Prevention Network/National
Birth Defects Prevention Study, Atlanta, Georgia. February 25, 2013.
8.
Feldkamp ML. Raising Birth Defects Awareness- Parent Advisory Group. Presented at the 16th
National Birth Defects Prevention Network/National Birth Defects Prevention Study, Atlanta,
Georgia. February 25, 2013.
Updated March 31, 2015
21
9.
Feldkamp ML: Standards for Birth Defects Surveillance: Assessment Tools. Presented at the
16th National Birth Defects Prevention Network/National Birth Defects Prevention Study, Atlanta,
Georgia. February 25, 2013.
10.
Feldkamp ML: Diet quality and risk of gastroschisis. Presented at the 16th National Birth Defects
Prevention Network/National Birth Defects Prevention Study, Atlanta, Georgia. February 26, 2013.
11.
Feldkamp ML: Update on Risk Factors for Birth Defects. Presented at the 40th International
Clearinghouse for Birth Defects Surveillance and Research, San Jose, Costa Rica. Dec 4, 2013.
12.
Feldkamp ML: Diet quality and risk of gastroschisis. Presented at the 40th International
Clearinghouse for Birth Defects Surveillance and Research, San Jose, Costa Rica. Dec 5, 2013.
13.
Hobbs CA. Conotruncal heart defects and interactions between lifestyle factors and genetic
variation in folate-related metabolic pathways. Oral presentation at International Clearinghouse for
Birth Defects Surveillance and Research 40th Annual Meeting, San Josè, Costa Rica. December 4,
2013.
14.
Hobbs CA. Genomic and epigenomic factors associated with nonsyndromic congenital heart
defects. Oral presentation at 6th International Conference on Birth Defects and Disabilities in the
Developing World, Cebu, Phillipines. November 13, 2013.
15.
Hobbs CA. Congenital heart defects, folic acid, and maternal dietary patterns: United States
National Birth Defects Prevention Study. Oral presentation at 9th International Conference on
Homocysteine and One-Carbon Metabolism Meeting, Dublin, Ireland. September 9, 2013.
16.
Hoyt AT, Canfield MA, Shaw GM, Waller DK, Duwe K, Ramadhani T, Anderka M, Scheuerle A,
and the National Birth Defects Prevention Study. Association of Selected Socio-demographic and
Acculturation Factors with Anotia/Microtia. Presented at the Combined Annual Meeting of the
National Birth Defects Prevention Network and the National Birth Defects Prevention Study,
Atlanta, GA, February 25-27, 2013.
17.
Langlois PH, Hoyt AT, Lupo PJ, Lawson CC, Waters MA, Reefhuis J, Shaw GM, Desrosiers TA,
Duwe KN, Gilboa SM, Moore CA, Correa A, Malik S, Romitti PA, Lammer EJ, Symanski E,
Khoder ZG, Agopian AJ, Lee L, Mitchell LE, Finnell RH, and the National Birth Defects
Prevention Study. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of
selected birth defects; A summary of four papers from the National Birth Defects Prevention Study.
Poster presented at the annual Teratology Society Meeting in Tucson AZ, June 2013.
18.
Liberman RF, Luke B, Stern JE, Reefhuis J, Gopal D, Anderka M. Validation of Maternal Selfreport of Assisted Reproductive Technology Use Among Massachusetts Participants in the National
Birth Defects Prevention Study. Society for Perinatal Epidemiology Research, Boston, June 2013.
19.
Lupo PJ, Mitchell LE, Canfield MA, Shaw GM, Olshan AF, Finnell RH, Zhu H; and the National
Birth Defects Prevention Study. Maternal-Fetal Metabolic Gene-Gene Interactions and Rish of
Neural Tube Defects. Poster presented at the 40th Annual Meeting of the International
Updated March 31, 2015
22
Clearinghouse for Birth Defects Research and Prevention. December 3-6, 2013. San Jose, Costa
Rica.
20.
Miquel-Verges F, Mosley BS, Block AS, Hobbs CA; National Birth Defects Prevention Study.
Prematurity and small for gestational age associated with birth defects, national birth defects
prevention study 1997-2007. Poster presented at 6th International Conference on Birth Defects and
Disabilities in the Developing World, Cebu, Philippines. November 13, 2013.
21.
Rocheleau CM, Bertke SJ, Lawson CC, Romitti PA, Desrosiers TA, Agopian AJ, Bell EM, Gilboa
SM. Demographic, behavioral, and reproductive history differences by maternal working status
before and during pregnancy: implications for reproductive studies. Oral presentation at the
National Birth Defects Prevention Network (NBDPN) Annual Meeting. Joint Meeting with the
National Birth Defects Prevention Study (NBDPS). February 2013.
22.
Rocheleau CM, Bertke SJ, Lawson CC, Romitti PA, Desrosiers TA, Agopian AJ, Bell EM, Gilboa
SM. Demographic, behavioral, and reproductive history differences by maternal working status
before and during pregnancy: implications for reproductive studies. Poster presented at the 46th
Annual Meeting of the Society for Epidemiologic Research. June 2013.
23.
Stingone JA, Luben TJ, Daniels JL, Fuentes M, Richardson DB et al. Investigating the impact of
folic-acid supplement use on the relationship between exposure to PM2.5 during early pregnancy
and congenital heart defects. 2013. Poster presented at Society for Pediatric and Perinatal
Epidemiologic Research Annual Meeting Boston, MA, June 18, 2013.
24.
Stingone JA, Luben TJ, Daniels JL, Fuentes M, Richardson DB et al. Maternal exposure to criteria
air pollutants during early pregnancy and congenital heart defects in offspring. 2013. Presentation
at Society for Epidemiologic Research Annual Meeting Boston, MA, June 20, 2013.
25.
Tang X, Nick T, Cleves MA, Erickson SW, Li M, Li J, MacLeod SL, Hobbs CA and the National
Birth Defects Prevention Study. Conotruncal heart defects and interactions between lifestyle factors
and folate and oxidative-stress related genetic variants. Poster presented at Arkansas Biosciences
Institute Fall Research Symposium. University of Arkansas for Medical Sciences, Little Rock, AR.
October 15, 2013.
26.
Van Bennekom CM, Mitchell AA, Moore CA, Werler MM, and the National Birth Defects
Prevention Study. Vasoactive exposures during pregnancy and risk of microtia. Poster presented at
annual meeting of National Birth Defects Prevention Network, Atlanta, GA, February 2013.
2012
27.
Brender J, Werler M, Kelley K, Vuong A, Shinde M, Huber Jr. J, Sharkey J, Zheng Q, Suarez L,
Langlois P, Canfield M, Romitti PA, Malik S; The National Birth Defects Prevention Study. (2011)
Nitrosatable drugs, dietary nitrites, and neural tube defects. Am J Epidemiol 173 (Suppl 11):S210.
Updated March 31, 2015
23
28.
Brender J, Weyer P, Romitti P, Horel S, Kantamneni J, Shinde M, Vuong A, Huber J, Sharkey J,
Langlois P, Suarez L, Canfield M. Prenatal nitrate intake from drinking water and selected birth
defects in offspring. Epidemiology 2012; 23(supp 5):s148.
29.
Brender J, Weyer P, Romitti P, Horel S, Kantamneni J, Shinde M, Vuong A, Huber C, Sharkey P,
Langlois P, Canfield M, Suarez L, and the National Birth Defects Prevention Study. Prenatal
nitrate intake from drinking water and birth defects in offspring. Poster presented at the 45th
Annual Meeting of the Society for Epidemiologic Research. June 27-30, 2012. Minneapolis, MN.
30.
Case A, Royle M, Scheuerle A, Carmichael S, Moffitt K, Ramadhani T. Attribution Theory,
Ethnicity, and Beliefs about Causes of Birth Defects. Oral presentation, Texas Birth Defects
Research Symposium, November 15, 2012.
31.
Cassell CH, KA Lee, D Mendez, RP Strauss, RE Meyer. Factors associated with time and distance
traveled to cleft and craniofacial care. Poster presented at the joint National Birth Defects
Prevention Network/National Birth Defects Prevention Study 2012 Annual Meeting, Arlington, VA,
February 27-29, 2012.
32.
Carmichael SL, Yang W, Shaw GM. (20120) Maternal dietary nutrient intake and risk of preterm
delivery. Pediatric Academic Societies annual meeting, Boston, MA, May, 2012; Society for
Pediatric and Perinatal Epidemiologic Research, Minneapolis, June, 2012.
33.
Dawson AL, Tinker SC, Jamieson DJ, Hobbs CA, Berry RJ, Anderka MT, Keppler-Noreuil KM,
Lin AE, Reefhuis J, and the National Birth Defects Prevention Study. Twinning and major birth
defects, National Birth Defects Prevention Study, 1997-2007. Poster presentation at the National
Birth Defects Prevention Network meeting in Washington, D.C. February 2012.
34.
Desrosiers TA. (2012) Maternal occupational exposure to organic solvents and selected congenital
anomalies Poster at joint National Birth Defects Prevention Network/National Birth Defects
Prevention Study 2012 Annual Meeting, February 27-29, 2012 in Arlington, VA.
35.
Desrosiers TA, Lawson CC, Meyer RE, Richardson DB, Daniels JL, Waters MA, van Wijngaarden
E, Langlois PH, Romitti PA, Correa A, Olshan AF, and the National Birth Defects Prevention
Study. Maternal occupational exposure to organic solvents and risk of neural tube defects and
orofacial clefts. Poster abstract accepted for joint National Birth Defects Prevention
Network/National Birth Defects Prevention Study 2012 Annual Meeting, February 27 - 29, 2012, in
Arlington, VA.
36.
Duwe KN, Alverson CJ, Callaghan W, Canfield M, Correa A, Duke CW, Marshall E, Olney R,
Reefhuis J, Romitti P, Gilboa S. Association between previous fetal loss and birth defects, National
Birth Defects Prevention Study (NBDPS), 1997-2007. Poster presented at the 45th Annual Meeting
of the Society for Epidemiologic Research. June 27-30, 2012. Minneapolis, MN.
37.
Erickson S, Chowdhury S, MacLeod SL, Cleves MA, Melnyk S, James SJ, Hu P, Hobbs CA.
Interactions between maternal genotypes and metabolites are associated with incidence of
congenital heart defects. Poster presentation at American Society of Human Genetics, Annual
meeting, San Francisco, November 9, 2012.
38.
Funk W, Sauter D, Olshan A, McDade T, Ghio A. Development of a method for assessing prenatal
exposures to heavy metals using state-archived dried blood spots. Poster presented at PPTOX III:
Updated March 31, 2015
24
Environmental Stressors in the Developmental Origins of Disease: Evidence and Mechanisms.
Paris, France, May 14-16, 2012.
39.
Glidewell MJ, J Reefhuis, SA Rasmussen, A Woomert, PA Romitti, C Hobbs, KS Crider, and the
National Birth Defects Prevention Center. Factors affecting maternal participation in the genetic
component of the National Birth Defects Prevention Study, United States, 1997-2007. Poster
presented at the joint National Birth Defects Prevention Network/National Birth Defects Prevention
Study 2012 Annual Meeting, Arlington, VA, February 27-29, 2012.
40.
Hobbs CA. Maternal epigenetic factors in congenital heart defects. Presented at the Cardiovascular
Joint Conference, Arkansas Children’s Hospital, Little Rock, Arkansas, April 2, 2012.
41.
Huber Jr. J, Zheng Q, Sharkey J, Brender J, Vuong A, Shinde M, Suarez L, Langlois P, Canfield
M, Romitti PA, Malik S; The National Birth Defects Prevention Study. (2011) Dietary nitrates,
nitrites and nitrosatable compounds and neural tube defects, oral clefts and limb deficiencies. Am J
Epidemiol 173 (Suppl 11):S297.
42.
Huiping Z, PJ Lupo, C Chapa, Wei Lu, AJ Agopian, LE Mitchell, GM Shaw, K Waller, A Olshan,
RH Finnell, MA Canfield. Diabetes and obesity-related genes and risk of neural tube defects in the
NBDPS. Poster presented at the joint National Birth Defects Prevention Network/National Birth
Defects Prevention Study 2012 Annual Meeting, Arlington, VA, February 27-29, 2012.
43.
Kingsley R, Martin R, Canfield MA, Bensyl D, Case AP, Farag NH. Health Indicators among
Women Before Pregnancy—Texas, 2002–2010. International Clearinghouse for Birth Defects
Prevention & Research (ICBDSR) and Canadian Congenital Anomalies Surveillance Network
(CCASN) Joint Annual Scientific Meeting October 30-November 2 2012 Ottawa.
44.
Knight JH, CH Cassell, RP Strauss, M Marcus, V White, EE Howell, RE Meyer. “Academic
Outcomes among School-Aged Children with and without Cleft Lip/Palate.” Presented at the 69th
Annual Meeting of the American Cleft Palate-Craniofacial Association, San Jose, CA, April 17-21,
2012.
45.
Knight KH, CH Cassell, M Marcus, V White, EE Howell, RE Meyer, RP Strauss. Parent-reported
academic outcomes among school-aged children with and without orofacial clefts in North
Carolina. Poster presented at the joint National Birth Defects Prevention Network/National Birth
Defects Prevention Study 2012 Annual Meeting, Arlington, VA, February 27-29, 2012.
46.
Langlois PH et al. (2012). Maternal occupational exposure to polycyclic aromatic hydrocarbons and
risk of birth defects. Oral presentation, Texas Birth Defects Research Symposium, November 15,
2012.
47.
Langlois PH, AT Hoyt, PJ Lupo, CC Lawson, MA Waters, TA Desrosiers, GM Shaw, PA Romitti,
EJ Lammer, and the National Birth Defects Prevention Study. Maternal occupational exposure to
polycyclic aromatic hydrocarbons and risk of oral cleft-affected pregnancies. Poster presented at
the joint National Birth Defects Prevention Network/National Birth Defects Prevention Study 2012
Annual Meeting, Arlington, VA, February 27-29, 2012.
48.
Lin S, Kielb C, Herdt-Losavio M, Bell E, Druschel C, Romitti P, Rocheleau C*, Lawson C, Waters
M, Stewart P, Olney R. (2011) Maternal Occupational Exposure to Pesticides and the Risk of
Musculoskeletal Birth Defects: A Preliminary Analysis. Birth Defects Res A Clin Mol Teratol
91:351. doi: 10.1002/bdra.20834
Updated March 31, 2015
25
49.
Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, Olney RS, Parker SE,
Werler MM. Maternal Medication and Herbal Use and Risk of Hypospadias: Data from the
National Birth Defects Prevention Study, 1997–2007. International Conference on
Pharmacoepidemiology and Therapeutic Risk Management 2012.
50.
Luben TJ, Siega-Riz AM, Herring A, Aylsworth AS, and the National Birth Defects Prevention
Study. The effect of maternal water consumption during pregnancy on birth defects. Poster
Presentation. Society for Pediatric and Perinatal Epidemiologic Research (SPER) Annual
Meeting. Minneapolis, MN, June 25-27, 2012.
51.
Lupo PJ, Symanski E, Langlois PH, Gilboa SM, Malik S, Lawson CC, Agopian A, Correa A,
Desrosiers T, Romitti PA, Shaw GM, Mitchell LE; The National Birth Defects Prevention Study.
(2011) Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and congenital
heart defects (CHDs) in offspring. Am J Epidemiol 173 (Suppl 11):S189.
52.
Lupo PJ, Langlois PH, Symanski E, Finnell RH, Reefhuis J, Agopian A, Lawson CC, Duwe KN,
Moore CA, Romitti PA, Shaw GM, Mitchell LE; The National Birth Defects Prevention Study.
(2011) Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and
gastroschisis in offspring. Am J Epidemiol 173 (Suppl 11):S190.
53.
Ma C, Shaw GM, Scheuerle AE, Canfield MA, Carmichael SL, and National Birth Defects
Prevention Study. (2012). Association of microtia with maternal nutrition. Teratology June, 2012.
54. Parker SE, Werler MM, Shaw GM, Anderka M, Yazdy MM, and the National Birth Defects
Prevention Study. Dietary Glycemic Index and the Risk of Birth Defect. National Birth Defects
Prevention Network annual meeting, Washington, D.C. February 2012.
55. Romitti PA for the NBDPS Cough Medications Work Group. Cough medications and birth defects.
Presented at NBDPN 15th Annual Meeting.
56.
Sanders A. “Toxic Metals and You, your Mother and your Child.” Seminar presented at
Environmental Sciences and Engineering (ESE) Seminars, University of North Carolina at Chapel
Hill-Chapel Hill. February 15, 2012.
57.
Sanders AP, TA Desrosiers, AH Herring, AF Olshan, R Meyer, RC Fry. Association between toxic
metals in private wells and birth defects prevalence. Poster presented at the joint National Birth
Defects Prevention Network/National Birth Defects Prevention Study 2012 Annual Meeting,
Arlington, VA, February 27-29, 2012. AWARD WINNING; First Place NBDPN poster award.
58.
Stingone J. “Exploring the Relationship Between Exposure to Air Pollutants and Cardiac Birth
Defects: Should We Be Telling Women to Watch What They Breathe?” (preliminary results).
Seminar presented at Reproductive, Perinatal, and Reproductive Epidemiology (RPPE) meeting,
University of North Carolina at Chapel Hill-Chapel Hill, February 1, 2012.
59.
Van Bennekom CM, Mitchell AA, Moore CA,Werler MM. Microtia: findings suggest no
association with vasoactive medications. [Abstract] Pharmacoepidemiol Drug Saf 2012;21 (Suppl.
3):15. Oral presentation, 28th annual International Conference on Pharamacoepidemiology,
Barcelona, Spain, August 2012.
60.
Weyer P, Romitti P, Islam M, Bell E, Browne M, Luben T, Meyer R, Langlois P, Anderka M,
Feldkamp M, Mosley B, Hobbs C, Reefhuis J, Tinker S. Drinking water disinfection byproducts
and orofacial clefts: preliminary analysis. Presented at NBDPN 15th Annual Meeting.
61.
Weyer P, Brender J, Horel S, Kantamneni J, Sharkey J, Shinde M, Vuong A, Langlois P, Romitti P.
(2012) Exposure assessment methods for drinking water nitrate in the National Birth Defects
Updated March 31, 2015
26
Prevention Study Am J Epidemiol 175 (Suppl 11):S18. doi: 10.1093/aje/kws258. Presented as a
poster in the SER 45th Annual Meeting.
62.
Weyer P, Romitti P, Horel S, Kantamneni J, Shinde M, Vuong A, Huber, Jr. J, Sharkey J, Langlois
P, Canfield M, Suarez L, National Birth Defects Prevention Study. Prenatal nitrate intake from
drinking water and selected birth defects in offspring. Am J Epidemiol 2012; 175(11 Suppl):S57.
63.
Yang W, Carmichael SL, Tinker SC, Shaw GM, & the National Birth Defects Prevention Study.
(2012). Association between weight gain during pregnancy and neural tube defects and
gastroschisis in offspring. Teratology June, 2012
64.
Zhou J. Nonparametric Bayes methods for estimation in high-dimensional contingency tables.
Poster presented 6/28/2012 at the 11th World Meeting of the International Society for Bayesian
Analysis (ISBA). Kyoto, Japan. June 25-29, 2012.
65.
Zhu H, Lupo PJ, Mitchell LE, Canfield MA, Shaw G, Waller K, Correa A, Olshan A Finnell RH,
and the National Birth Defects Prevention Study. Maternal Diabetes/Obesity and Neural Tube
Defects: The Genetic Link. Presented at the 6th International Symposium on Diabetes &
Pregnancy. Oral presentation, Texas Birth Defects Research Symposium, November 15, 2012.
2011
66.
Agopian AJ, Canfield MA, Olney RS, Lupo PJ, Ramadhani T, Mitchell LE, Shaw GM, Moore CA,
and the National Birth Defects Prevention Study. Maternal race/ethnicity and sub-phenotypes of
spina bifida in the National Birth Defects Prevention Study (NBDPS). Presented as at the
International Neural Tube Defects Symposium, Austin, Texas, November 6-9, 2011.
67.
Agopian AJ, Canfield MA, Olney RS, Lupo PJ, Ramadhani T, Mitchell LE, Shaw GM, Moore CA,
and the National Birth Defects Prevention Study. Maternal race/ethnicity and sub-phenotypes of
spina bifida in the National Birth Defects Prevention Study (NBDPS). Presented as poster at the
24th Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research. June 2021, 2011, Montreal, Quebec, Canada.
68.
Agopian AJ, Canfield MA, Olney RS, Lupo PJ, Ramadhani T, Mitchell LE, Shaw GM, Moore CA,
National Birth Defects Prevention Study. Spina Bifida Subtypes and Sub-phenotypes by Maternal
Race/Ethnicity in the National Birth Defects Prevention Study. The 32nd David W. Smith Workshop
on Malformations and Morphogenesis. September 2011. Lake Arrowhead, California.
69.
Agopian AJ, Eastcott LM, Mitchell LE. Age of Onset in Genome-wide Association Studies. Third
North American Congress of Epidemiology. June 2011. Montreal, Quebec, Canada.
70.
Agopian AJ, Eastcott LM, Mitchell LE. Age of Onset in Genome-wide Association
Studies. Society for Pediatric and Perinatal Epidemiologic Research Annual Meeting. June 2011.
Montreal, Quebec, Canada.
71.
Brender J, Werler M, Kelley K, Vuong A, Shinde M, Huber, Jr. J, Sharkey J, Zheng Q, Surez L,
Langlois P, Canfield M, Romitti P, Malik S. Nitrosatable drugs, dietary nitrites, and neural tube
defects. 3rd North American Congress of Epidemiology Conference/Annual Meeting of the Society
for Epidemiologic Research (SER). June 22-24, 2011. Montreal, Quebec, Canada.
Updated March 31, 2015
27
72.
Brender J, Werler M, Kelley K, Vuong A, Shinde M, Huber Jr. J, Sharkey J, Zheng Q, Suarez L,
Langlois P, Canfield M, Romitti PA, Malik S, The National Birth Defects Prevention Study.
Nitrosatable drugs, dietary nitrites, and neural tube defects. Presented as a poster at the 24th Annual
Meeting of the Society for Pediatric and Perinatal Epidemiologic Research (SPER).
73.
Carmichael SL, Yang W, Feldkamp ML, Munger RG, Siega-Riz AM, Botto LD, Shaw GM. Diet
quality and neural tube defects and orofacial clefts. Society for Pediatric and Perinatal
Epidemiologic Research, Montreal, June, 2011; Teratology Society, Coronado, CA, June, 2011;
International NTD Meeting, Austin, TX, September, 2011.
74.
Caspers KM, Romitti PA, Bayman L, Lin S, Olney R, Werler MM, Holmes LB, and the National
Birth Defects Prevention Study. (2011) Maternal periconceptional exposure to cigarette smoking
and limb deficiencies. Am J Epidemiol 173 (Suppl 11):S136. Poster presentation at the Society for
Epidemiologic Research 44th Annual Meeting / 3rd North American Congress of Epidemiology.
75.
Caspers KM, Romitti PA, Bayman L, Lin S, Olney R, Werler MM, Holmes LB, and the National
Birth Defects Prevention Study. (2011) Maternal periconceptional exposure to cigarette smoking
and limb deficiencies. Poster presentation at the 24rd Annual Society for Pediatric and Perinatal
Epidemiologic Research Meeting.
76.
Desrosiers TA,. (2011) Maternal occupational exposure to organic solvents and selected congenital
anomalies. Poster presented at Society for Pediatric and Prenatal Epidemiologic Research (SPER).
Montreal, Canada; June 2011.
77.
Desrosiers, TA. “Maternal occupational exposure to organic solvents during early pregnancy and
selected congenital anomalies”. Poster presented at annual meeting of North American Congress of
Epidemiology (SER). Montreal, Canada, June 2011.
78.
Duong H, Canfield MA, Hoyt A, Waller DK. Structural Malformations and Hot Tubs. Presented at
the International Neural Tube Defects Symposium, Austin, Texas, November 6-9, 2011.
79.
Erickson SW. Maternal Genotypes and Folate-Related Metabolites Implicated in Congenital Heart
Defects. Presented at the UAMS Department of Biostatistics, Little Rock, AR, September 6, 2011.
80.
Feldkamp ML, Srisukhumbowornchai S, Olney R, Romitti P, Richardson SD, Botto LD. Selfreported periconceptional maternal tobacco exposure and the risk for omphalocele. Presented as a
poster at the ICBD 5th Int’l Conference.
81.
Glidewell MJ, Reefhuis J, Rassmussen SA, Woomert A, Romitti PA, Crider KS, The National Birth
Defects Prevention Study. Participation in the genetic component of the National Birth Defects
Prevention Study, 1997-2007. Presented as a poster at the24th Annual Meeting of the Society for
Pediatric and Perinatal Epidemiologic Research (SPER).
82.
Gordon VK, Hobbs CA, Cleves MA, MacLeod SL, Erickson SW. Maternal genetics, obesity, and
non-syndromic heart defects. Poster presented at UAMS Student Research Day, Little Rock, AR,
April 11, 2011.
83.
Hobbs CA. Maternal epigenetic and genetic factors in congenital heart defects. Mexican
Association of Human Genetics. Presented at Genomics of Congenital Malformations Symposium.
Merida, Yucatan, November 16-19, 2011.
Updated March 31, 2015
28
84.
Hobbs CA. Congenital heart defects and haplotype tagging SNPs in folate-related pathways.
Presented at Genomics of Congenital Malformations Symposium. Merida, Yucatan, November 1619, 2011.
85.
Hobbs CA. Public Health Genomics: case studies in neonatal health. Presented at Arkansas
Department of Health, County Health Officer Symposium. Winthrop Rockefeller Institute, Petit
Jean, AR, October 16, 2011.
86.
Hobbs CA. Advances in Genomics, Epigenomics, and National Pediatric Studies. Presented at
Arkansas Biosciences Institute Fall Research Symposium. Little Rock, AR, September 21, 2011.
87.
Hobbs CA. Birth defects and neonatal health: old questions, new tools. Presented at Arkansas
Department of Health Grand Rounds. Little Rock, AR, April 21, 2011.
88.
Hobbs CA. Birth defects and neonatal health: old questions, new tools. Presented at the University
of Arkansas for Medical Sciences, College of Medicine. Little Rock, AR, March 15, 2011.
89.
Huber Jr. J, Zheng Q, Sharkey J, Brender J, Vuong A, Shinde M, Suarez L, Langlois P, Canfield
M, Romitti PA, Malik S; The National Birth Defects Prevention Study. (2011) Dietary nitrates,
nitrites and nitrosatable compounds and neural tube defects, oral clefts and limb deficiencies. Am J
Epidemiol 173 (Suppl 11):S297.
90.
Huber, Jr, Q Zheng, J Sharkey, J Brender, A Vuong, M Shinde, L Suarez, P Langlois, M Canfield,
P Romitti, S Malik, and the National Birth Defects Prevention Study. Dietary Nitrates, Nitrites and
Nitrosatable Compounds and Neural Tube Defects, Oral Clefts and Limb Deficiencies. Poster
presented at the SER 44th Annual Meeting/ 3rd North American Congress of Epidemiology.
91.
Kancherla V, Romitti PA, Sun L, Burns TL, Carey JC, Siega-Riz AM, Druschel CM, Lin A..
Epidemiology of Choanal Atresia
92.
The National Birth Defects Prevention Study. Poster presented at the annual meeting of the Society
for Pediatric & Perinatal Epidemiologic Research (SPER), in Montreal, Canada, June 2011.
93.
Kancherla V, Romitti PA, Burns TL, Carey JC, Siega-Riz AM, Druschel CM, Lin A, Sun L; The
National Birth Defects Prevention Study. (2011) Epidemiology of choanal atresia: The National
Birth Defects Prevention Study. Am J Epidemiol 173 (Suppl 11):S134. Poster presentation at SER
44th Annual Meeting / 3rd North American Congress of Epidemiology.
94.
Khodr ZG, Lupo PJ, Canfield MA, Case AP, Agopian A, Carmichael SL, Shaw GM, Royle MH,
Mitchell LE, and the National Birth Defects Prevention Study. Identification of Predictors for
Preconceptional Folic Acid Supplementation. Gulf Coast Women's Health Research Forum,
September 30, 2011, Houston, TX. Clinical Science Poster Award Winner.
95.
Khodr ZG, Lupo PJ, Canfield MA, Case AP, Agopian A, Carmichael SL, Shaw GM, Royle MH,
Mitchell LE, and the National Birth Defects Prevention Study. Identification of Predictors for
Preconceptional Folic Acid Supplementation. Seventh International Conference on Neural Tube
Defects, November 6-9, 2011, Austin, TX.
96.
Langlois PH, Hoyt AT, Lupo PJ, Lawson CC, Waters MA, Desrosiers TA, Shaw GM, Romitti PA,
Lammer EJ, the National Birth Defects Prevention Study. Maternal occupational exposure to
polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnancies.
International NTD Conference, Austin TX, November 2011.
Updated March 31, 2015
29
97.
Lin S, Kielb C, Herdt-Losavio M, Bell E, Druschel C, Romitti P, Rocheleau C*, Lawson C, Waters
M, Stewart P, Olney R. (2011) Maternal Occupational Exposure to Pesticides and the Risk of
Musculoskeletal Birth Defects: A Preliminary Analysis. Birth Defects Res A Clin Mol Teratol
91:351. doi: 10.1002/bdra.20834
98.
Lin S, Kielb C, Herdt-Losavio M, Bell E, Druschel C, Romitti P, Rocheleau*C, Lawson C, Waters
M, Stewart P, Olney R. Maternal occupational exposure to pesticides and the risk of
musculoskeletal birth defects: a preliminary analysis. Presented as a poster at the Teratology
Society 51st Annual Meeting.
99.
Lupo PJ, Langlois PH, Symanski E, Finnell RH, Reefhuis J, Agopian A, Lawson CC, Duwe KN,
Moore CA, Romitti PA, Shaw GM, Mitchell LE; The National Birth Defects Prevention Study.
(2011) Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and
gastroschisis in offspring. Am J Epidemiol 173 (Suppl 11):S190. Presented as a poster at the SER
44th Annual Meeting/ 3rd North American Congress of Epidemiology
100. Lupo PJ, Langlois PH, Symanski E, Finnell RH, Reefhuis J, Agopian A, Lawson CC, Duwe KN,
Moore CA, Romitti PA, Shaw GM, Mitchell LE, The National Birth Defects Prevention Study.
Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and gastroschisis in
offspring. Presented as a poster at the 24th Annual Meeting of the Society for Pediatric and
Perinatal Epidemiologic Research (SPER).
101. Lupo PJ, Mitchell LE, Canfield MA, Shaw GM, Waller DK, Correa A, Olshan AF, Finnell RH,
Zhu H. Glucose homeostasis genes and the risk of neural tube defects in the National Birth Defects
Prevention Study. Poster presented at the 24th Annual Meeting of the Society for Pediatric and
Perinatal Epidemiologic Research (SPER). June 2011, Montreal, Quebec, Canada.
102. Lupo PJ, Symanski E, Langlois PH, Gilboa SM, Malik S, Lawson CC, Agopian A, Correa A,
Desrosiers T, Romitti PA, Shaw GM, Mitchell LE; The National Birth Defects Prevention Study.
(2011) Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and congenital
heart defects (CHDs) in offspring. Am J Epidemiol 173 (Suppl 11):S189. Presented as poster at the
SER 44th Annual Meeting / 3rd North American Congress of Epidemiology.
103. Lupo PJ, Symanski E, Langlois PH, Gilboa SM, Malik S, Lawson CC, Agopian A, Correa A,
Desrosiers T, Romitti PA, Shaw GM, Mitchell LE; The National Birth Defects Prevention Study.
Maternal occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and congenital heart
defects (CHDs) in offspring. Presented as poster at the 24th Annual Meeting of the Society for
Pediatric and Perinatal Epidemiologic Research (SPER).
104. Lupo PJ, Symanski E, Langlois PH, Gilboa SM, Malik S, Lawson CC, Agopian A, Correa A,
Desrosiers TA, Romitti PA, Shaw GE, Mitchell LE, National Birth Defects Prevention Study.
Maternal occupational exposure to polycyclic aromatic hydrocarbons and the risk of congenital
heart defects in offspring. The 3rd North American Congress of Epidemiology. June 21-24, 2011.
Montreal, Quebec, Canada.
Updated March 31, 2015
30
105. Meyer RE. “From research to prevention: National Birth Defects Prevention Study results ready for
translation.” Presented at the 14th Annual Meeting of the National Birth Defects Prevention
Network, Orlando, FL, February 28 - March 2, 2011.
106. Meyer RE, TA Desrosiers, AM Siega-Riz. “Restricted carbohydrate intake and neural tube defects:
preliminary results from the National Birth Defects Prevention Study.” Poster presented at the 14th
Annual Meeting of the National Birth Defects Prevention Network, Orlando, FL, February 28 March 2, 2011.
107. Romitti P, Malik S, the National Birth Defects Prevention Study. Dietary Nitrates, Nitrites and
Nitrosatable Compounds and Neural Tube Defects, Oral Clefts and Limb Malformations. Poster
presented at the 3rd North American Congress of Epidemiology Conference/Annual Meeting of the
Society for Epidemiologic Research. June 22-24, 2011. Montreal, Quebec, Canada.
108. Sharkey J, Brender J, Horel S. Nitrate exposure to Mexican American women of childbearing age
from bottled water and maquina de aqua. Epidemiology 2011; 22 (suppl):S162.
109. Waller DK, Duong HT, Hashmi SS, Ramadhani T, Scheuerle A, Canfield MA. Maternal use of hot
tubs and major structural birth defects. Presented at the International Neural Tube Defects
Symposium. November 6-9, 2011. Austin, Texas.
110. Waller DK, Duong HT, Hashmi SS, Ramadhani T, Scheuerle A, Canfield MA. Maternal use of hot
tubs and major structural birth defects. The Teratology Society 51st Annual Meeting. June 25-29,
2011. San Diego, California.
111. Weyer P, Brender J, Horel S, Kantamneni J, Sharkey J, Shinde M, Vuong A, Langlois P, Romitti P.
(2012) Exposure assessment methods for drinking water nitrate in the National Birth Defects
Prevention Study Am J Epidemiol 175 (Suppl 11):S18. doi: 10.1093/aje/kws258
112. Zhu H, Lupo PJ, Mitchell LE, Canfield MA, Shaw G, Waller K, Correa A, Olshan A Finnell RH,
and the National Birth Defects Prevention Study. Maternal Diabetes/Obesity and Neural Tube
Defects: The Genetic Link. Presented at the 6th International Symposium on Diabetes & Pregnancy.
March 23-26, 2011, Salzburg, Austria.
2010
113. Ahrens K, Yazdy MM, Mitchell AA, Werler MM. Folic Acid Intake and Spina Bifida in the Era of
Dietary Folic Acid Fortification. Platform presentation at 23rd Annual Meeting of the Society for
Pediatric and Perinatal Epidemiologic Research (SPER), Seattle, WA, June 2010.
114. Anderka M, Flaherty K, Higgins C, Wolfgang M, Borger C, Getz K. Incorporating Prenatally
Diagnosed Cases into a Population-Based Birth Defects Surveillance Program. National Birth
Defects Prevention Network, Washington DC, Poster, March 10, 2010.
115. Canfield MA, Ramadhani T, Waller DK, Correa A, Royle M . Pregnancy related behavioral risk
factors: the difference between US and foreign born parents among racial/ethnic groups.. 16th
Annual Maternal and Child Health Epidemiology Conference, San Antonio, TX, December 15-17,
2010.
116. Canfield MA. National Birth Defects Prevention Study: Race, Ethnicity, Nativity and
Acculturation: Recent Findings and Ongoing Projects. Presented in a session on the National Birth
Defects Prevention Study at the 13th Annual Meeting of the National Birth Defects Prevention
Network, Washington, DC, March 8-10, 2010. [Invited speaker]
Updated March 31, 2015
31
117. Carmichael SL, Cogswell M, Ma C, Olney RS, Correa A, Shaw GM. Hypospadias and maternal
phytoestrogen intake. American College of Epidemiology, San Francisco, CA, September, 2010.
118. Carmichael SL, Ma C, Correa A, Olney RS, Shaw GM. Hypospadias and potentially estrogenic
nutrients. Society for Pediatric and Perinatal Epidemiologic Research, Seattle, CA, June 2010; and
the National Birth Defects Prevention Network Annual Meeting, Washington, DC, February, 2010.
119. Case A, Royle M, Scheuerle A, Carmichael S, Mitchell L. What Do You Think Causes Birth
Defects? A Content Analysis of Mothers’ Responses in the National Birth Defects Prevention
Program Study. 16th Annual Maternal and Child Health Epidemiology Conference, San Antonio,
TX, December 15-17, 2010.
120. Caspers KM, Oltean C, Romitti PA, Sun L, Pober B, Rasmussen SA, Yang W, Druschel CM, and
the NBDPS. (2010) Maternal periconceptional exposure to cigarette smoking and alcohol
consumption and congenital diaphragmatic hernia. (Poster presentation at the 23rd Annual Society
for Pediatric and Perinatal Epidemiologic Research Meeting).
121. Caton AR, Bell EM, Druschel CM, Werler MM, Browne ML, McNutt LA, Romitti PA.
Periconceptional beta blocker use and severe hypospadias. Poster Presentation, Society for
Epidemiologic Research 43rd Annual Meeting, Seattle, Washington, June 2010.
122. Caton AR, Bell EM, Druschel CM, Werler MM, Browne ML, McNutt LA, Romitti PA.
Antihypertensive medication use during pregnancy and the risk of orofacial clefts. Poster
Presentation, Society for Pediatric and Perinatal Epidemiologic Research 23rd Annual Meeting,
Seattle, Washington, June 2010.
123. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Maternal hypertension, antihypertensive medication use, and the risk of
selected birth defects, Oral Presentation, Annual Meeting of the Centers for Birth Defects Research
and Prevention, Decatur, Georgia, January 2010.
1. Feldkamp ML, Gastroschisis: A Journey to Discover the Pieces of the Puzzle Presented at the 50th
Teratology Society Meeting, Louisville, Kentucky June 27, 2010.
2. Feldkamp ML, Carey JC, Pimentel R, Krikov S , Botto LD, Is gastroschisis truly a sporadic defect?
Familial cases of gastroschisis in Utah, 1997 to 2008. Presented at the Society for Pediatric and
Perinatal Epidemiology June 2010, David W. Smith Workshop, August 29, 2010 and the International
Clearinghouse for Birth Defects Surveillance and Research, November 1, 2010.
124. Hartman R, Colarusso T, Lin A, Frías J, Patel S, Duwe K, Correa A, Rasmussen S. Descriptive
Study of Atrioventricular Septal Defects in the National Birth Defects Prevention Study, 19972005. National Birth Defects Prevention Network, March 10, 2010, Washington, D.C., Poster.
125. Hobbs CA. National Birth Defects Prevention Study Focus on Over-the-Counter and Prescription
Medications. 50th Annual Meeting of The Teratology Society in conjunction with the 23rd Annual
education conference Organization of Teratology Information Specialists. Louisville, KY. June
2010.
126. Hobbs CA, Cleves MA, MacLeod S, Erickson S. Conotruncal Heart Defects Associated with SNPs
in 61 Genes in Three Folate-Related Candidate Pathways. Presented at Pediatric Academic
Societies Meeting. Vancouver, British Columbia, May 2010.
Updated March 31, 2015
32
127. Keppler-Noreuil K, Caspers KM, Sun L, Carey JC, Romitti PA and the National Birth Defects
Prevention Study. (2010) Clinical and risk factor analysis of cloacal exstrophy in the National Birth
Defects Prevention Study (NBDPS). (Oral presentation at the 31st Annual David W. Smith
Workshop on Malformations and Morphogenesis).
128. Lin AE, Krikov S, Riehle-Colarusso T, Belmont J, Geva T, Anderka M, Botto LD. Laterality
Defects in the National Birth Defects Prevention Study: Descriptive Epidemiology. Am College
Med Genet, March 26, 2010, Albuquerque, NM, Poster.
129. Lin AE, Krikov S, Riehle-Colarusso T, Belmont J, Geva T, Anderka M, Getz K, Botto LD.
Laterality Defects in the National Birth Defects Prevention Study: Occurrence, Racial/Ethnic
Analysis, and Defect Patterns. David W. Smith Workshop on Malformations and Morphogenesis,
August 28, 2010, Alderbrook, WA, Poster.
130. Ma C, Carmichael SL, Scheuerle AC, Canfield MA, Shaw GM. Anotia and microtia in infants
associated with maternal obesity and periconceptional folic acid use. Society for Pediatric and
Perinatal Epidemiologic Research, Seattle, CA, June 2010.
131. Ramadhani T. The association between pregnancy-related risk factors and nativity status, by
race/ethnicity. 16th Annual Maternal and Child Health Epidemiology Conference. December 15-17,
2010, San Antonio, TX.
132. Ramadhani T, Short V, Canfield MA, Waller DK, Royle M, Correa A, Scheuerle A and the
National Birth Defects Prevention Study Birth defects in Non-Hispanic Blacks: Are they Related to
Mothers’ Nativity? Presented as poster at the Annual Meeting of the National Centers for Birth
Defects Research and Prevention, January 26-27, 2010, Decatur, GA.
133. Rocheleau C, Romitti PA, Sanderson W, Bell E, Druschel CM. (2010) Effect of survey instrument
on participation: a randomization study of a mailed questionnaire versus a computer-assisted
telephone interview. Am J Epidemiol 171 (Suppl 11):S146. Poster presentation at the 43rd Annual
Society for Epidemiologic Research Meeting.
134. Rocheleau CM, Romitti PA, Sanderson WT, Lawson CC, Sun L, Waters MA, Stewart PA, Reefhuis
J, Olney RS, and the National Birth Defects Prevention Study. (2010) Maternal occupational
pesticide exposure and risk of hypospadias in the National Birth Defects Prevention Study. (Poster
presentation at the 23rd Annual Society for Pediatric and Perinatal Epidemiologic Research
Meeting).
135. Romitti PA, Druschel CM, Sun L, Browne ML, Botto LD, Lin AE, and the National Birth Defects
Prevention Study (NBDPS). (2010) Maternal periconceptional alcohol consumption and
cardiovascular malformations (CVM)s. Am J Epidemiol 171 (Suppl 11):S9. Poster presentation at
the 43rd Annual Society for Epidemiologic Research Meeting.
2009
136. Anderka M. Using the NBDPS to study maternal medication use in pregnancy. National Birth
Defects Prevention Network Annual Meeting. February 2009.
137. Broussard CS, Louik C, Reefhuis J, Moore CA, Honein MA. Association of Periconceptional
Ginkgo Biloba Use with Selected Major Birth Defects. National Birth Defects Prevention Network
Annual Meeting, Feb 2009, Nashville, TN.
Updated March 31, 2015
33
138. Broussard CS, Rasmussen SA, Reefhuis J, Riehle-Colarusso T, Friedman JM, Jann MW, Honein
MA, and the National Birth Defects Prevention Study. Early-Pregnancy Opioid Analgesic
Treatment and Risk for Congenital Heart Defects. International Conference on
Pharmacoepidemiology and Therapeutic Risk Management, August 2009, Providence, RI; David
W. Smith Meeting on Malformations and Morphogenesis, August 2009, Philadelphia, PA; Annual
Meeting of the Teratology Society, July 2009, Puerto Rico.
139. Broussard CS, Rasmussen SA, Reefhuis J, Riehle-Colarusso T, Friedman JM, Jann MW, Honein
MA. Early-Pregnancy Opioid Analgesic Treatment and Risk for Congenital Heart Defects.
Pharmacoepidemiology and Drug Safety 2009;18:S199-200.
140. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Honein MA. Early-Pregnancy
Opioid Analgesic Treatment and Risk for Congenital Heart Defects. Birth Defects Research (Part
A) 2009;85:411.
141. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Honein MA, and the National
Birth Defects Prevention Study. Early-Pregnancy Opioid Analgesic Treatment and Risk for
Congenital Heart Defects—United States, 1997–2004. Epidemic Intelligence Service Conference,
April 2009, Atlanta, GA.
142. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Honein MA. Maternal Opioid
Analgesic Treatment and Risk for Major Birth Defects. National Birth Defects Prevention Study
Annual Meeting, January 2009, Decatur, GA.
143. Canfield MA, Olney RS, Moore C, Ramadhani T, Lupo PJ, Shaw GM, Mitchell LE; National Birth
Defects Prevention Study. Clinical Subtypes of Spina Bifida by Maternal Race/Ethnicity in the
National Birth Defects Prevention Study. Oral presentation at Sixth International Neural Tube
Defects Conference. September 12-15, 2009, Burlington, VT.
144. Canfield MA, Ramadhani TA, Shaw GM, Carmichael SL, Waller DK, Mosley BS, Royle MH,
Olney RS, and the National Birth Defects Prevention Study. Anencephaly and Spina Bifida among
Hispanics: Acculturation Factors in the National Birth Defects Prevention Study. Oral presentation
at the Annual Meeting of the National Centers for Birth Defects Research and Prevention. January
2009, Atlanta, GA.
145. Canfield MA, Ramadhani TA, Shaw GM, Carmichael SL, Waller DK, Mosley BS, Royle MH,
Olney RS, and the National Birth Defects Prevention Study. Anencephaly and Spina Bifida among
Hispanics: Acculturation Factors in the National Birth Defects Prevention Study. Poster presented
at the Annual Meeting of the National Birth Defects Prevention Network. February 2009, Nashville,
TN.
146. Canfield MA, Ramadhani T, Shaw GM, Waller DK, Carmichael SL, Mosley B, Olney RS, and the
National Birth Defects Prevention Study. Are offspring of less acculturated Hispanic parents at
higher risk for spina bifida and anencephaly? Poster presented at a research conference sponsored
by the UT School of Nursing Center for Health Promotion Research, entitled “Promoting Health in
Underserved Populations: Health Disparities, from Local to Global”, Austin, TX, February 18,
2009.
147. Carmichael SL, Lammer EJ, Rasmussen SA, Ma C, Shaw GM. Sagittal synostosis and maternal
nutrient intake. Teratology, San Juan, Puerto Rico, June, 2009.
148. Derrington T, Donahue S, Weiss J, Kotelchuck M, Lin AE, Riehle-Colarusso T, Correa A. Using a
Unique Linked Data System to Assess Live Birth Prevalence, Co-occurring Birth Defects, and Case
Fatality Rates among Infants with Down Syndrome in Massachusetts, 2001-2005. National Birth
Defects Prevention Network Annual Meeting; Nashville, TN: February 24, 2009.
Updated March 31, 2015
34
3. Feldkamp ML, Stone MB, Carmichael SL, Shaw GM, Moore CA, Botto LD, Maternal Nutrition and Risk
for Gastroschisis: Findings from the National Birth Defect Prevention Study. Presented at the 49th
Teratology Society Meeting, Puerto Rico June 2009 and International Clearinghouse for Birth Defects
Research and Prevention, Salt Lake City September 2009.
149. Fisk Green, R, Devine O,Crider KS, Olney RS, Archer N, Olshan A, Shapira SK, Association of
Paternal Age and Risk for Congenital Anomalies from the National Birth Defect Prevention Study,
1997-2004. Poster presented at the annual meeting of The American Society of Human Genetics,
November 2008, Philadelphia, Pennsylvania). Poster presented at the National Birth Defects and
Prevention Network Annual Meeting, February 2009 in Nashville, TN.
150. Gripp KW, Lin AE (updated May 2009) Costello Syndrome in: GeneReviews at GeneTests:
Medical Genetics Information Resource [database online]. Copyright, University of Washington,
Seattle. 1997-2009. Available at http://www.genetests.org
151. Grisenbeck J, Steck M, Huber, Jr. J, Sharkey J, Rene A, Brender J. Development of estimates of
dietary nitrates, nitrites, and nitrosamines for use with the Short Willet Food Frequency
Questionnaire. Am J Epidemiol 2009; 169(Suppl):S119.
152. Hobbs CA, Weedn A, Mosley BS, Waller DK, Canfield M, Correa A, Cleves MA. Prenatal
diagnosis of birth defects in the National Birth Defects Prevention Study. Poster presented at the
49th Annual Teratology Society Meeting. Rio Grande, Puerto Rico. June 2009.
153. Hobbs CA. The (US) National Birth Defects Prevention Study: Epidemiological Approach
Emphasizing Genitourinary System Anomalies. Poster presented at 7th Annual Canadian
Congenital Anomalies Surveillance Network Scientific Meeting. Ottawa, Canada. November 2009.
154. Lin AE. Session Organizer and Moderator of Plenary Session, “Here’s Looking at You:
Craniofacial Defects”. National Defects Prevention Network Annual Meeting. Nashville, TN,
February 22, 2009. Plenary.
155. Lin AE Invited speaker. Branchio-Oculo-Facial syndrome: Cardinal Signs. American College of
Medical Genetics, Tampa, Florida. March 28, 2009.
156. Lin AE The Robert L. Summtt, Sr. MD, “Distinguished Visiting Professorship in Medical
Genetics”, University of Tennessee, LeBonheur Children’s Hospital, Memphis, TN, May 27,
2009. “The Family of the Ras’MAPK Pathway Syndromes: Noonan Syndrome and Kissin’
Cousins”; “Getting Started in Medical Writing”; “Aortic Dilation and Dissection in Turner
Syndrome”.
157. Lupo PJ, Symanski E, Chan W, Waller DK, Canfield MA, Langlois PH, Mitchell LE; National
Birth Defects Prevention Study. An Evaluation of the Validity of Using Composite Endpoints for
Neural Tube Defects in the National Birth Defects Prevention Study. Oral presentation at Sixth
International Neural Tube Defects Conference. September 12-15, 2009, Burlington, VT.
158. Malik S. Congenital heart defects: Environmental and genetic factors. CDC Birth Defects
Surveillance Regional Meeting. Little Rock, AR. May 2009.
159. Ramadhani T, Canfield MA, Waller DK, Royle M, Correa A, and the National Birth Defects
Prevention Study. Variation in pregnancy-related risk behaviors and maternal conditions among
U.S.- and foreign-born mothers, by race/ethnicity. Poster presented at the 12th Annual Meeting of
the National Birth Defects Prevention Network, Nashville, TN, February 23-25, 2009.
160. Tinker SC, Reefhuis J, Dellinger AM, Jamieson DJ. “Epidemiology of maternal injuries during
pregnancy, National Birth Defects Prevention Study, 1997-2005.” Presented at the 49th Teratology
Society Annual Meeting. Rio Grande, Puerto Rico, June 2009.
Updated March 31, 2015
35
161. Weedn A. Maternal report of prenatally diagnosed birth defects in the National Birth Defects
Prevention Study. Poster presented at the Pediatric Academic Societies Annual Meeting. Baltimore,
MD. May 2009; poster presented at the 6th Annual Heartland Genetics and Newborn Screening
Collaborative Conference. Little Rock, AR. September 2009.
162. Werler MM. Anti-Epileptic Medications and Birth Defects. National Birth Defects Prevention
Study Annual Meeting, January, 2009.
163. Yazdy M, Liu S, Mitchell AA, Werler MM. Maternal dietary glycemic intake and the risk of neural
tube defects. Student Prize Paper and platform presentation at Society for Pediatric and Perinatal
Research, Anaheim, CA, June 2009. http://www.sper.org/FinalProgram-2009.pdf
2008
164. Bell EM, Chen L, Caton AR, Druschel CM, Lin S. Air pollutants and birth defects in New York
State, Poster Presentation, National Birth Defects Prevention Network Annual Meeting,
Washington, DC, February 2008.
165. Broussard CS, Friedman JM, Rasmussen SA, Reefhuis J, Jann MW, Honein MA, and the NBDPS.
Therapeutic opioid analgesic use before and during pregnancy, National Birth Defects Prevention
Study (NBDPS), 1997-2003. Pharmacoepidemiology and Drug Safety 2008;17:S156.
166. Broussard CS, Friedman JM, Rasmussen SA, Reefhuis J, Jann MW, Honein MA, and the National
Birth Defects Prevention Study. Therapeutic opioid analgesic use before and during pregnancy,
National Birth Defects Prevention Study, 1997-2003. International Conference on
Pharmacoepidemiology and Therapeutic Risk Management, August 2008, Copenhagen, Denmark;
Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research, June 2008,
Chicago, IL.
167. Broussard CS, Louik CA, Honein MA, Mitchell AA, and the National Birth Defects Prevention
Study. Herbal use before and during pregnancy – United States, 1998-2003. Epidemic Intelligence
Service Conference, April 2008, Atlanta, GA.
168. Broussard CS, Louik CA, Honein MA, Mitchell AA, and the National Birth Defects Prevention
Study. Herbal use before and during pregnancy. National Birth Defects Prevention Network Annual
Meeting, Feb 2008, Washington, DC.
169. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Honein MA. Maternal Opioid
Analgesic Treatment and Risk for Major Birth Defects: Preliminary Results from the National Birth
Defects Prevention Study, 1997-2004. Maternal and Child Health Epidemiology Conference,
December 2008, Atlanta, GA.
170. Broussard CS, Reefhuis J, Friedman JM, Rasmussen SA, Jann MW, Honein MA, and the National
Birth Defects Prevention Study. Opioid analgesic treatment during pregnancy and adverse fetal
outcomes. Pharmacoepidemiology and Drug Safety 2008;17:S161.
171. Broussard CS, Reefhuis J, Friedman JM, Rasmussen SA, Jann MW, Honein MA. Opioid analgesic
treatment during pregnancy and adverse fetal outcomes: Results from the National Birth Defects
Prevention Study, 1997-2003. Birth Defects Research (Part A) 2008;82:306.
172. Broussard CS, Reefhuis J, Friedman JM, Rasmussen SA, Jann MW, Honein MA, and the National
Birth Defects Prevention Study. Opioid analgesic treatment during pregnancy and adverse fetal
outcomes: Results from the National Birth Defects Prevention Study, 1997-2003. International
Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 2008,
Copenhagen, Denmark; Annual Meeting of the Teratology Society, July 2008, Monterey, CA.
Updated March 31, 2015
36
173. Browne ML, Caton AR, Rasmussen SA, Druschel CM, Lin AE, Canfield MA, Romitti PA, Hoyt
AT, and the National Birth Defects Prevention Study. Maternal thyroid disease and cardiovascular
malformations in the National Birth Defects Prevention Study. Poster presented at the 11th Annual
Meeting of the National Birth Defects Prevention Network, Washington, D.C., February 2008.
174. Browne ML, Caton AR, Rasmussen SA, Hoyt AT, Druschel CM, Lin AE, Waller DK, Canfield
MA, Romitti PA. Maternal thyroid disease and cardiovascular malformations in the National Birth
Defects Prevention Study. Presented at the 48th Annual Meeting of the Teratology, Monterey,
California, June 28–July 2, 2008.
175. Canfield MA, Ramadhani T, Shaw GM, Waller DK, Carmichael SL, Mosley B, Olney RS, and the
National Birth Defects Prevention Study. Are less acculturated Hispanic parents at higher risk for
having offspring with neural tube defects. Poster presented at the Texas Birth Defects Research
Symposium, Lubbock, TX, October 2008.
176. Canfield MA, Ramadhani T, Shaw GM, Waller DK, Carmichael SL, Mosley B, Olney RS, and the
National Birth Defects Prevention Study. Are offspring of less acculturated Hispanic parents at
higher risk for spina bifida and anencephaly? Poster presented at the 41st Annual Society for
Epidemiologic Research Meeting, Chicago, Illinois, June 2008.
177. Carmichael SL, Yang W, Correa A, Olney RS, Shaw GM. Hypospadias and intake of nutrients
related to one-carbon metabolism. Teratology, Monterey, CA, June, 2008 and MCH Epi
Conference, Atlanta, December, 2008.
178. Caton A. Invited Symposium: Understanding fetal risks of antihypertensive medication use during
pregnancy, Oral Presentation, Panel Member, International Conference on Pharmacoepidemiology
and Therapeutic Risk Management, Copenhagen, Denmark, August 2008.
179. Chowdhury S. Risk of congenital limb defects and polymorphisms in folate pathway genes.
Arkansas Biosciences Institute Fall Research Symposium. Little Rock, AR, October 2008.
180. Cogswell ME, Bitsko R, Anderka M, Caton A, Feldkamp M, Meyer R, Ramadhani T, Robbins J,
Shaw G, Hockett Sherlock S, Reefhuis J; National Birth Defects Prevention Study. Does selection
method affect representativeness of controls? National Birth Defects Prevention Study, 1997-2003.
21st Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research (SPER),
Chicago, IL, June 2008.
181. Cogswell M, Bitsko R, Anderka M, Caton A, Feldkamp M, Meyer R, Ramadhani T, Robbins J,
Shaw G, Sherlock SH, Reefhuis J. Does selection method affect representativeness of
controls? National Birth Defects Prevention Study. Am J Epidemiol 2008;167(Suppl):S111.
182. Collier S, Dollard S, Mei J, Honein M, Hannon WH, Frias JL, Shaw GM, Meyer R, Chaing S,
Canfield MA, Rasmussen SA. The contribution of CMV to hydrocephalus: A pilot study using
newborn dried blood spots. Presented at the Congenital Cytomegalovirus Conference, Atlanta, GA,
November 2008.
183. Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti
PA, and the National Birth Defects Prevention Study. Alcohol Consumption by Women Before and
During Pregnancy. Poster presented at Poster presented at the Texas Birth Defects Research
Symposium, Lubbock, TX, October 2008.
4. Feldkamp ML, Carey JC, Pimentel R, Krikov S , Botto LD, Is gastroschisis truly a sporadic defect?
Familial cases of gastroschisis in Utah, 1997 to 2008. Presented at the Society for Pediatric and
Updated March 31, 2015
37
Perinatal Epidemiology June 2010, David W. Smith Workshop, August 29, 2010 and the International
Clearinghouse for Birth Defects Surveillance and Research, November 1, 2010.
5. Fisk Green, R, Devine O,Crider KS, Olney RS, Archer N, Olshan A, Shapira SK, Association of Paternal
Age and Risk for Congenital Anomalies from the National Birth Defect Prevention Study, 1997-2004.
Poster presented at the annual meeting of The American Society of Human Genetics, November 2008,
Philadelphia, PA.
184. Jenkins MM, Gallagher ML, Rasmussen SA, Sturchio C, Koontz DA, Richter P, Collier S, Honein
MA, and the National Birth Defects Prevention Study. Evaluation of the quality and quantity of
DNA from buccal samples in the National Birth Defects Prevention Study. Poster
presentation, American Society of Human Genetics Meeting, San Diego, CA, Oct 2007; Poster
presentation, 10 yr Anniversary meeting of the National Office of Public Health Genomics, Atlanta,
GA, Jan 2008.
185. MacLehose RF. Bayesian adjustments for misclassification of maternal smoking. Centers for
Disease Control and Prevention (invited talk), Atlanta GA; January 2008.
186. Olshan AF. Incorporating study of genetic risk factors into the National Birth Defects Prevention
Study. Teratology Society Annual Meeting, Monterey CA; July 2008.
187. Ramadhani T, Canfield MA, Waller DK, Royle M, Correa A, and the National Birth Defects
Prevention Study. Variation in pregnancy-related risk factors among foreign- vs. US-born mothers,
by race/ethnicity. Poster presented at the Texas Birth Defects Research Symposium, Lubbock, TX,
October 2008.
188. Ramadhani T, Canfield MA, Waller K, Royle M, Correa A, and the National Birth Defects
Prevention Study. Variation in pregnancy-related risk behaviors and maternal conditions among
United States and foreign born mothers by race/ethnicity. Poster presented at the 41st Annual
Society for Epidemiologic Research Meeting, Chicago, Illinois, June 2008.
189. Ramadhani T, Canfield MA, Waller K, Royle M, Correa A, and the National Birth Defects
Prevention Study. Variation in pregnancy-related risk behaviors and maternal conditions among
United States and foreign born mothers by race/ethnicity. Poster presented at the National Birth
Defects and Prevention Network 11th Annual Meeting, February 2008 in Washington, D.C.
190. Ramadhani T, Canfield MA, Waller K, Royle M, Correa A, Angela Scheuerle and the National
Birth Defects Prevention Study. Variation in pregnancy-related risk behaviors and maternal
conditions among United States and foreign born mothers by race/ethnicity. Poster presented at the
Texas Birth Defects Research Symposium, Lubbock, TX, October 2008.
191. Ramadhani T, Short V, Canfield MA, Waller DK, Correa A, Royle M, Scheuerle A, and the
National Birth Defects Prevention Study. Birth defects in non-Hispanic blacks: Are they related to
mothers’ birth nativity? Poster presented at the Texas Birth Defects Research Symposium, Lubbock,
TX, October 2008.
192. Ramadhani T, Short V, Canfield MA, Waller K, Royle M, Correa A, Scheuerle A, and the National
Birth Defects Prevention Study. Birth defects in Hispanics: Are they related to mothers’ birthplace?
Poster presented at the National Birth Defects and Prevention Network Annual Meeting, February
2008 in Washington, D.C.
193. Rauen KA, Hefner E, Carrillo K, Taylor J, Messier L, Aoki Y, Gripp KW, Matsubara Y, Proud VK,
Hammond P, Allanson JE, Delrue MA, Axelrad ME, Lin AE, Doyle DA, Kerr B, Carey JC,
McCormick F, Silva AJ, Kieran MW, Hinek A, Nguyen TT, Schoyer L, Molecular Aspects,
Clinical Aspects and Possible Treatment Modalities for Costello Syndrome: Proceedings from the
Updated March 31, 2015
38
1st International Costello Syndrome Research Symposium 2008. Am J Med Genet Part A
146A:1205-1217.
194. Romitti PA, Druschel CM, Sun L, Browne ML, Botto LD, Lin AE. (2008) Maternal
periconceptional alcohol consumption and cardiovascular malformations. (Poster presentation at the
21st Annual Society for Pediatric and Perinatal Epidemiologic Research Meeting)
195. Romitti PA, Sun L, Herring A, Druschel CM, Mitchell A, Werler M, Louik C, Olney RS. Maternal
periconceptional use of dextromethorphan and selected birth defects. (2008) (Poster presentation at
the 24th Annual International Society for Pharmacoepidemiology Meeting) Poster Award Winner:
Medicines in Pregnancy.
196. Siega-Riz AM. Maternal obesity, diabetes, and nutrients: their role in birth defects. National Birth
Defects Network Meeting, Washington DC; February 2008.
2007
197. Bitsko, RH, Reefhuis, J, Feldkamp, M, Werler, M, Waller, K, Frias, J, Honein, M (2007).
Periconceptional Use of Weight-Loss Products Including Ephedra and the Association with Birth
Defects — The National Birth Defects Prevention Study, 1997–2003. Epidemic Intelligence
Service Conference, April 16-20, Atlanta, GA.
198. Bitsko, RH, Reefhuis, J, Feldkamp, M, Werler, M, Waller, K, Frias, J, Honein, M (2007).
Periconceptional Use of Weight-Loss Products and the Association with Birth Defects. 40th Annual
Society for Epidemiologic Research (SER) Meeting, June 19-22, Boston, Massachusetts.
199. Bitsko, RH, Reefhuis, J, Feldkamp, M, Werler, M, Waller, K, Frias, J, Honein, M (2007).
Periconceptional use of weight-loss products and the association with birth defects. Twentieth
Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research (SPER), June
18-19, Boston, Massachusetts.
200. Canfield MA, Shaw G, Ramadhani T, Waller K, Mosley B, Carmichael S, Royle M, Olney R. Folic
acid and NTDs in Hispanics and Whites: National Birth Defects Prevention Study, 1999-2003.
Invited presentation at the National Center on Birth Defects and Developmental Disabilities,
Centers for Disease Control and Prevention for the National Birth Defects Prevention Study.
Atlanta, GA, August 2007.
201. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal
corticosteriod use and orofacial clefts. . Maternal and Child Health Epidemiology Conference,
Atlanta, December, 2006 and National Birth Defects Prevention Network, San Antonio, TX,
February 2007.
202. Carmichael SL, Ma C, Rasmussen SA, Honein MA, Lammer EJ, Shaw GM. Craniosynostosis and
maternal smoking. Teratology, Philadelphia, June, 2007.
203. Carter TC, et al. Lower genital tract infection and birth defects. Teratology Society Annual Meeting,
Pittsburgh, PA, June 2007.
204. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Antihypertensive medication use during pregnancy, Oral Presentation,
Maternal and Child Health Epidemiology Annual Meeting, Atlanta, Georgia, December 2007.
205. Caton A, Bell E, Druschel C, Werler M, Mitchell A, Browne M, McNutt L, Romitti P, Olney R,
Correa A. Maternal hypertension, antihypertensive medication use, and the risk of severe
hypospadias, Poster Presentation, Society for Paediatric and Perinatal Epidemiologic Research
20th Annual Meeting, Boston, Massachusetts, June 2007.
Updated March 31, 2015
39
206. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Antihypertensive medication use and congenital heart defects, Oral
Presentation, National Birth Defects Prevention Network Annual Meeting, San Antonio, Texas,
February 2007.
207. Cleves MA, Karim MA, MacLeod SL, Hobbs CA. Congenital Hearts, Maternal Genetic
Susceptibility and Pro-oxidant Lifestyle Factors. Presented at the International Genetic
Epidemiology 16th Annual Meeting, York, England, United Kingdom. September 8, 2007 to
September 9, 2007.
208. Correa A, Besser LM, Gilboa SM, Botto L, Moore CA, Hobbs CA, Cleves M, Riehle-Colarusso T,
Waller DK, Reece EA. Spectrum of birth defects associated with maternal diabetes. Presented at
National Birth Defects Prevention Study Meeting, November 2006 in Atlanta, GA and National
Birth Defects and Prevention Network Annual Meeting February 2007 in San Antonio, Texas, and
the American Diabetes Association Scientific Sessions, Chicago, IL, June 2007.
6. Feldkamp ML, Reefhuis J, Kucik J, Krikov S, Wilson A, Moore CA, Carey JC, Botto LD, Maternal
Genitourinary Infections and the Risk of Gastroschisis - National Birth Defects Prevention Study, 19972003. Presented at the David Smith Workshop August 2007.
209. Hashmi SS, Waller DK, Langlois PH, Rasmussen SA and Hecht JT. Maternal Hyperthermia and
Orofacial Clefting – Preliminary Results from the National Birth Defects Prevention Study.
Presented at the Centers for Birth Defects Research and Prevention Annual Meeting, November
2007, Atlanta, Georgia.
210. Herring AM, Romitti PA, Sun L, Druschel CM, Werler MM, Louik C, Mitchell AA, Olney R, and
the National Birth Defects Prevention Study. (2007) Association between dextromethorphan and
guaifenesin exposure and selected birth defects. (Poster presentation at the University of Iowa
Research Week).
211. Hobbs CA. Birth defects and folic acid intake. College of Public Health, UAMS, January 11, 2007.
212. Hobbs CA. Maternal Biomarkers and Birth Defects. Presented at the 6th Conference on
Homocysteine Metabolism World Congress on Hyperhomocysteinemia, Saarbruecken, Germany.
June 8, 2007.
213. Hobbs CA. Molecular Epidemiological Tool Kit for Personalized Medicine. Presented at the 47th
Annual Meeting of the Teratology Society. Pittsburgh, PA. June 28, 2007.
214. Hobbs CA. Neural tube defect: Translating research into prevention. 2007 University of Arkansas
for Medical Sciences Perinatal Conference. Little Rock, Arkansas, January 25, 2007.
215. Hobbs CA. Risk of congenital heart defects. 2007 NBDPN 10th Annual Meeting, San Antonio,
Texas) February 6, 2007.
216. Lin S, Bell E, Munsie JP, Browne M, Druschel C, Romitti PA, Mitchell A, Lin AE, Olney RS and
the National Birth Defects Prevention Study. Maternal asthma medication use and the risk of birth
defects. National Birth Defects Prevention Network Meeting, February 2007, Austin, TX.
217. Lin S, Bell E, Munsie JP, Browne M, Druschel C, Romitti PA, Mitchell A, Lin AE, Olney RS and
the National Birth Defects Prevention Study. Maternal asthma medication use and the risk of
gastrochisis. Society for Pediatric and Perinatal Epidemiology, June 2007, Boston, MA.
218. Lin S, Bell E, Munsie JP, Browne M, Druschel C, Romitti PA, Mitchell A, Lin AE, Olney RS and
the National Birth Defects Prevention Study. Maternal asthma medication use and the risk of
selected birth defects. Society for Pediatric and Perinatal Epidemiology, June 2007, Boston, MA.
Updated March 31, 2015
40
219. Lin S, Munsie JP, Bell E, Druschel C, Romitti PA, Mitchell A, Olney RS and the National Birth
Defects Prevention Study. Maternal astma medication use and the risk of gastroschisis. (2007
UCSF-CHE Summit on Environmental Challenges to Reproductive Health and Fertility, San
Francisco, CA).
220. Malik S. Urinary tract infection in pregnancy as a risk factor for congenital heart defects. American
Heart Association Annual Scientific Session. Orlando, FL. November 2007.
221. Ramadhani T, Ethen MK, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA.
Alcohol consumption by women in the U.S. before and during pregnancy. Poster presented at the
2nd International Conference on Fetal Alcohol Spectrum Disorders, March 2007, Victoria, British
Columbia, Canada.
222. Ramadhani T, Short V, Canfield MA, Waller K, Royle M, Correa A, Scheuerle A, and the National
Birth Defects Prevention Study. Birth defects in Hispanics: Are they related to mothers’ birthplace?
Poster presented at the Centers for Birth Defects Research and Prevention 2007 Annual Meeting,
Atlanta, GA, November 2007.
223. Schmidt RJ, Romitti PA, Burns TL, Murray JC, Druschel C, Browne M, Olney RS, and the
National Birth Defects Prevention Study. (2007) Maternal caffeine intake, select metabolic gene
variants and neural tube defects. (Oral presentation at the 5th International NTD Conference).
224. Schmidt RJ, Romitti PA, Burns TL, Murray JC, Druschel C, Browne M, Olney RS, and the
National Birth Defects Prevention Study. (2007) Maternal caffeine intake, select metabolic gene
variants and neural tube defects. (Poster presentation at the American College of Epidemiology
Annual Meeting).
225. Schmidt RJ, Romitti PA, Burns TL, Murray JC, Druschel C, Browne M, Olney RS, and the
National Birth Defects Prevention Study. (2007) Maternal caffeine intake, select metabolic gene
variants and neural tube defects. (Poster presentation at the University of Iowa Department of
Epidemiology Poster Day).
226. Shapira SK, Werler MM, Moore CA, and Holmes LB. Clinical and epidemiological features of
amniotic band syndrome and limb-body wall complex. Presentation at the David W. Smith
Workshop on Malformations and Morphogenesis, August 8-12 2007, Williamsburg, VA.
227. Shapira SK, Werler MM, Moore CA, and Holmes LB. Clinical Phenotype and Maternal Factors
Involved in Amniotic Band Syndrome. Poster presented at the National Birth Defects and
Prevention Network Annual Meeting, February 2007 in San Antonio, Texas.
228. Wong-Gibbons DL, Romitti PA, Sun L, Olshan A, Reefhuis J, Moore C, Bell E, and the National
Birth Defects Prevention Study. (2007) Smoking, alcohol and esophageal atresia with or without
tracheo-esophageal fistula (EA ± TEF). (Poster presentation at the University of Iowa Research
Week).
2006
229. Bingay, E, Casey, L, Anderka, M. Supplementing Ascertainment of Hypospadias Cases in MA
with Medical Records from an Pediatric Outpatient Clinic. Presented as a poster at the National
Birth Defects Prevention Network Annual Meeting 2006.
230. Brown M, Druschel C, Mitchell A, Bell E, Lin A, Romitti P, and Correa A. Maternal caffeine
consumption and risk of septal and obstructive cardiovascular malformations in the National Birth
Defects Prevention Study. Presented at the National Birth Defects and Prevention Network Annual
Meeting, January 2006 in Arlington, Virginia.
Updated March 31, 2015
41
231. Browne ML, Durschel CM, Mitchell AA, Romitti PA, Lin AE, Correa A. Maternal caffeine
consumption and risk of cardiovascular malformations in the National Birth Defects Prevention
Study. (2006 NBDPN 9th Annual Meeting, San Francisco, CA).
232. Canfield MA, Ramadhani T, Shaw GS, Mosely B, Waller DK, Carmichael SC, Olney R, Royle M.
Periconceptional folic acid and neural tube defects in Hispanics and non-Hispanic whites. Presented
at the Annual Meeting of the National Centers for Birth Defects Research and Prevention, Atlanta,
GA, November 2006.
233. Carter TC, et al. Antifungal drugs and the risk of selected birth defects. Conference on Health
Promotion. September 2006.
234. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Antihypertensive medication use and congenital heart defects, Oral
Presentation, Maternal and Child Health Epidemiology Annual Meeting, Atlanta, Georgia,
December 2006.
235. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Maternal high blood pressure, antihypertensive medication use, and
cardiovascular malformations, Oral Presentation, Annual Meeting of the Centers for Birth Defects
Research and Prevention, Atlanta, Georgia, November 2006.
236. Caton A, Bell E, Druschel C, Werler M, Mitchell A, Browne M, McNutt L, Romitti P, Olney R,
Correa A. Maternal high blood pressure, antihypertensive medication use, and severe hypospadias,
Poster Presentation, Annual Meeting of the Centers for Birth Defects Research and Prevention,
Atlanta, Georgia, November 2006.
237. Caton A, Bell E, Druschel C, Werler M, Lin A, Mitchell A, Browne M, McNutt L, Romitti P,
Olney R, Correa A. Antihypertensive medications and cardiovascular malformations, Poster
Presentation, Society for Paediatric and Perinatal Epidemiologic Research 19th Annual Meeting,
Seattle, Washington, June 2006.
238. Ethen MK, Ramadhani T, Scheuerle A, Canfield M, Wyszynski D, Druschel C, Romitti PA, and the
National Birth Defects Prevention Study. Alcohol consumption by women before and during
pregnancy. (2006 NBDPN 9TH Annual Meeting, Arlington, VA).
239. Ethen MK, Ramadhani T, Scheuerle AS, Canfield MA, Wyszynski D, Druschel C, Romitti P.
Alcohol Consumption Patterns Before and During Pregnancy. Presented at the Texas Birth Defects
Research Conference, April 2006, Austin, Texas..
240. Fisk Green R, Olney R, Reefhuis J, Botto L, and Romitti P. Maternal reports of family history from
the National Birth Defects Prevention Study, 1997-2001. Poster presented at the National Birth
Defects and Prevention Network Annual Meeting, January 2006 in Arlington, Virginia.
241. Gilboa SM, Olshan AF, Werler MM, Correa A. Antihistamine use during pregnancy and selected
birth defects. Presented at MCH Epidemiology Conference, December 2006 in Atlanta, GA.
242. Herring AM, Romitti PA, Sun L, Druschel CM, Werler MM, Louik C, Mitchell AA, Olney R, and
the National Birth Defects Prevention Study. (2006) Association between dextromethorphan and
guaifenesin exposure and selected birth defects. (Poster presentation at the University of Iowa
Department of Epidemiology Poster Day).
243. Hobbs CA, Mosley BS, Shaw GM, Siega-Riz AM, Waller DK, Canfield M, Zhao W, Cleves MA
and the National Birth Defects Prevention Study. Neural tube defects and periconceptional intake of
micronutrients following mandatory folic acid fortification. Presented at the National Birth Defects
and Prevention Network 9th Annual Meeting, January 2006 in Arlington, Virginia.
Updated March 31, 2015
42
244. Jenkins MM, Rose KL, Woomert A, Romitti PA. Sample recollection using an improved cytobrush
methodology. Am J Hum Genet 2006; 79:2253B. Poster presented at the 2006 American Society of
Human Genetics Meeting, in New Orleans, LA.
245. Lin S, Bell E, Munsie JP, Browne M, Druschel C, Romitti PA, Mitchell A, Line AE, Olney RS and
the National Birth Defects Prevention Study. Maternal asthma medication use and the risk of birth
defects. (2006 12th Annual MCH EPI Conference, Atlanta, GA).
246. Manning SE, Rasmussen SA, Reefhuis J, and Honein MA. Association between Maternal Tobacco
Smoke and Alcohol Exposure and the Occurrence of Anorectal Atresia/Rectal Stenosis. Poster
presented at the National Birth Defects and Prevention Network Annual Meeting, January 2006 in
Arlington, Virginia.
247. Rasmussen SA, Yazdy M, Honein M, Carmichael SL, Canfield M. Maternal thyroid disease as a
possible risk factor for craniosynostosis, National Birth Defects Prevention Study, 1997-2002. Birth
Defects Res Part A Clin Mol Teratol 76:323, 2006.
248. Rasmussen SA, Yazdy M, Honein MA, Carmichael S, Canfield M. Maternal thyroid disease as a
possible risk factor for craniosynostosis – National Birth Defects Prevention Study. Presented at the
Annual David Smith Dysmorphology Workshop. September 2006. Lake Arrowhead, CA.
249. Rasmussen SA, Yazdy M, Honein M, Carmichael S, Canfield M, and the National Birth Defects
Prevention Study. Maternal Thyroid Disease as a Possible Risk Factor for Craniosynostosis,
National Birth Defects Prevention Study, 1997-2002. Presented at the Annual Meeting of the
Teratology Society. June 2006. San Diego, CA.
250. Reefhuis J, Always S, Rasmussen SA, Olney RS, and Friedman JM. Maternal Use of Selective
Serotonin Reuptake Inhibitors and Risk for Birth Defects. Presented at the National Birth Defects
and Prevention Network Annual Meeting, January 2006 in Arlington, Virginia.
251. Reefhuis J, Honein MA, Schieve L, Correa A, Hobbs CA, Rasmussen SA. Infertility treatments and
the risk for neural tube defects, oral clefts, and hypospadias. Proceedings of the Greenwood
Genetics Center 25:120-121, 2006.
252. Shapira SK, Werler MM, Moore CA, and Holmes LB. Maternal Factors Involved in Amniotic Band
Syndrome. Poster presented at the National Birth Defects and Prevention Network Annual Meeting,
January 2006 in Arlington, Virginia.
253. Shapira SK, Werler MM, Moore CA, and Holmes LB. Maternal factors involved in amniotic band
syndrome. Presentation at the American College of Medical Genetics Annual Meeting, March 23-26
2006, San Diego, CA.
254. Shaw GM, Carmichael SL, Laurent C, and Rasmussen SA. Maternal Nutrient Intakes and Risks of
Human Orofacial Clefts. Presented at the National Birth Defects and Prevention Network Annual
Meeting, January 2006 in Arlington, Virginia.
255. Smith VJ, Jenkins MM, Sturchio C, Gallagher M, Hobbs CA. Self-collected buccal cell samples:
DNA yield and participation rates. Am J Hum Genet 2006; 79:2267A. (Poster presented at the 2006
American Society of Human Genetics Meeting, in New Orleans, LA.
256. Waller DK, Gallaway MS, Canfield MC, Hernandez-Diaz S, Louik C. The use of hormonal
contraceptives in the periconceptional period and the occurrence of structural malformations. Poster
presented at the Annual Meeting of the National Centers for Birth Defects Research and
Prevention. Atlanta, GA. November 2006.
257. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Correa A, and
Gallaway MS. Maternal Obesity and Birth Defects – Preliminary Results from the National Birth
Updated March 31, 2015
43
Defects Prevention Study. Presented at the National Birth Defects and Prevention Network Annual
Meeting, January 2006 in Arlington, Virginia.
258. Wong-Gibbons DL, Romitti PA, Sun L, Olshan A, Reefhuis J, Moore C, Bell E, and the National
Birth Defects Prevention Study. (2006) Smoking, alcohol and esophageal atresia with or without
tracheo-esophageal fistula (EA ± TEF). (Poster presentation at the University of Iowa Department
of Epidemiology Poster Day).
2005
259. Alwan S, Reefhuis J, Rasmussen S, Olney R, and Friedman JM, and the National Birth Defects
Prevention Study. Maternal use of selective serotonin reuptake inhibitors and risk for birth
defects. Am J Epidemiol, 2005;161(Suppl):S95.
260. Anderka M, Mitchell AA, Louik C, Werler MM, Hernandez-Diaz S, Rasmussen SA, and the
National Birth Defects Prevention Study. Using the National Birth Defects Prevention Study to
investigate nausea and vomiting of pregnancy. Proceedings of the Society for Pediatric and
Perinatal Epidemiologic Research, June 2005.
261. Bell EM et al. Maternal asthma medication use and the risk of conotruncal heart malformations.
National Birth Defects Prevention Study Partners Meeting, November 2005.
262. Bingay, E, Casey, L, Anderka, M. Supplementing Case Ascertainment in MA with Outpatient
Medical Records from a Genetics Clinic. Presented as a poster at the National Birth Defects
Prevention Network Annual Meeting 2005.
7. Botto LD, Feldkamp M, Carey JC. Actual causes of congenital heart defects: a population based study,
Utah 1999-2003. Presented at the American Society of Human Genetics, SLC, UT, 2005.
263. Browne ML, Druschel CM, Mitchell AA, Romitti PA, Lin AE, Correa A, Bell EM, and the
National Birth Defects Prevention Study. Maternal caffeine consumption and risk of conotruncal
heart anomalies in the National Birth Defects Prevention Study. Proceedings of the Society for
Pediatric and Perinatal Epidemiologic Research, June 2005.
264. Carmichael S, et al. Hypospadias and Maternal Intake of Progestins and Oral Contraceptives.
Presented at Teratology, Vancouver, June, 2004; NCBDDD Annual Meeting, Washington, DC June
2004; International Clearinghouse for Birth Defects Monitoring & Research, Valletta, Malta,
September 2005.
265. Carmichael SL, Shaw GM, Laurent C, Olney RS, Lammer EJ, and the National Birth Defects
Prevention Study. Hypospadias and potential correlates of maternal estrogen levels. Teratology, St.
Pete Beach, Florida, June 2005.
266. Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle M, Canfield M. Correlates of
intake of folic acid-containing supplements among pregnant women. National Birth Defects
Prevention Network, Scottsdale, AZ, January 2005.
267. Ethen MK, Ramadhani T, Scheuerle AS, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA.
Alcohol consumption patterns before and during pregnancy. Presentation by Mark Canfield, Ph.D.
to Center on Birth Defects and Developmental Disabilities Conference in Washington D.C.
November 2005.
268. Fisk Green R, Olney R, Reefhuis J, Botto J, Romitti PA and the National Birth Defects Prevention
Study. Maternal reports of family history from the National Birth Defects Prevention Study, 19972001. (2005 ASHG 55th Annual Meeting, Salt Lake City, UT).
Updated March 31, 2015
44
269. Hobbs CA. Fourth Annual Birth Defects Structural Meeting. Congenital Heart Defects, Genes and
Metabolites. Washington, DC. October 6, 2005.
270. Hobbs CA. Prenatal growth patterns among infants with congenital heart disease. 2005 NBDPN 8th
Annual Meeting, Scottsdale, Arizona, January 25, 2005.
271. Hobbs CA, Cleves MA, Malik SA, Parsian A, Zhao W; National Birth Defects Prevention Study.
Congenital Heart Defects, Maternal Genetic Susceptibility and Pro-oxidant Lifestyle Factors.
Centers for Research and Prevention Annual Meeting. Atlanta, Georgia. November 2005.
272. Honein MA, Rasmussen SA, Reefhuis J, Moore CA, Romitti P, Correa A, Watkins M, Lammer E
and the National Birth Defects Prevention Study. Maternal tobacco smoke exposure and the
occurrence of oral clefts: Results from the National Birth Defects Prevention Study. Proceedings of
he Greenwood Genetics Center 24:89, 2005.
273. National Center for Toxicological Research, Food and Drug Administration, and the UAMS
Department of Pediatrics Retreat. Birth Defects – A Complex Problem. Little Rock, Arkansas.
September 17, 2005.
274. Reefhuis J, Honein M, Schieve L, Correa A, Hobbs C, Rasmussen S, and the National Birth Defects
Prevention Study. Assisted reproductive techniques and selected major birth defects. Data from
the NBDPS, 1997-2001. Am J Epidemiol, 2005;161(Suppl):S49.
275. Siega-Riz AM, Olshan A, Smith J, Werler M, Moore C, and the National Birth Defects Prevention
Study. Fat intake and the risk of gastroschisis. Proceedings of the Society for Pediatric and
Perinatal Epidemiologic Research, June 2005.
276. Siega-Riz AM. Fat intake and the risk of gastrochisis. National Birth Defects Prevention Meeting,
Scottsdale Arizona; January 2005.
277. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Correa A, and
Gallaway MS. Maternal Obesity and Birth Defects – Preliminary Results from the National Birth
Defects Prevention Study. Presented at the 4th Canadian Congenital Anomalies Surveillance
Network, November 2005, Ottawa, Canada.
278. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Correa A, and
Gallaway MS. Maternal Obesity and Birth Defects – Preliminary Results from the National Birth
Defects Prevention Study. Presented at the Texas Birth Defects Research Conference, April 2005,
Austin, Texas.
2004
279. Bell EM. Asthma medication use and asthma in New York State. National Birth Defects Prevention
Study Annual Meeting, November 2004.
280. Bell EM. Asthma medication use and the risk of cardiovascular malformation. National Center for
Birth Defects and Development Disabilities Conference, September 2004.
281. Bell EM. Maternal asthma medication use and the risk of cardiovascular malformations. National
Birth Defects Prevention Study Annual Meeting, November 2004.
282. Burgio, J, Lin, A, Higgins, C, Winship, S, Casey, L., Anderka, M. Supplemental Approaches to
Case Ascertainment in Massachusetts III: Faster ascertainment by faxing queries to physicians.
Presented as a poster at the National Birth Defects Prevention Network Annual Meeting 2004.
283. Cleves MA, Savell V, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA Maternal use of
acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDS), and muscular ventricular
Updated March 31, 2015
45
septal defects. Presentation by Bridget S. Mosley, MPH, to National Center on Birth Defects and
Developmental Disabilities Conference in Washington D.C. in July 2004.
284. Higgins, C, Burgio, J, Casey, L, Anderka, M. Supplemental Approaches to Case Ascertainment in
Massachusetts II: Finding MA birth defect cases in Rhode Island. Presented as a poster at the
National Birth Defects Prevention Network Annual Meeting 2004.
285. Hobbs CA. CDC Birth Defects Regional Meeting. Abdominal Wall Defects. Little Rock,
Arkansas. May 13, 2004.
286. Hobbs CA. Centers for Birth Defects Research and Prevention 2004 Annual Meeting. NTDs and
Micronutrients. San Antonio, Texas. November 16, 2004.
287. Hobbs CA. Exploring the Etiology of Complex Birth Defects. Society for Gynecologic
Investigation Annual Scientific Meeting, Houston, Texas. March 25, 2004.
288. Honein MA, Rasmussen SA, Reefhuis J, Moore CA, Romitti P, Correa A, Watkins ML, Lammer
EJ, and the National Birth Defects Prevention Study. Maternal smoking, environmental tobacco
smoke, and the risk of oral clefts. Am J Epidemiol 2004;159(11):S8. Presented at 2004 SER 37th
Annual Meeting, Salt Lake City, UT.
289. Langlois P, Wyszynski D, Royle M, Robbins J, Scheuerle A, del Junco D. Utility of retaining
questions on parental military service. Poster presented at the Centers for Birth Defects Research
and Prevention Annual Meeting, November 2004.
290. Lin AE. The National Birth Defects Prevention Study. The New England Medical Center/The
Floating Hospital, Dept. of Pediatrics, Medical Genetics Clinical Conference. June 14, 2004.
291. Lin, S, Bingay, E, Higgins, C, Karamuri, S, Anderka, M. Supplemental Approaches to Case
Ascertainment in Massachusetts I: Ascertainment of cardiovascular malformations from outpatient
cardiology clinics. Presented as a poster at the National Birth Defects Prevention Network Annual
Meeting 2004.
292. Louik C, et al. Herbal Use in Pregnancy: Results from Two Studies. Presented at National Center
on Birth Defects and Developmental Disabilities Conference in Washington D.C. in July 2004.
293. Louik C, Honein MA, Werler MM, Mitchell AA. Use of herbal products during pregnancy.
International Society for Pharmacoepidemiology, August 2004.
294. Reefhuis et al. Evaluation of an association between loratadine and hypospadias United States
1997-2001. Presented at National Center on Birth Defects and Developmental Disabilities
Conference in Washington D.C. in July 2004.
295. Reefhuis J, Honein M, Rasmussen S, Correa A, Hobbs C, Scheuerle A, Schieve L. Assisted
reproductive techniques and the risk of oral clefts: Data from the National Birth Defects Prevention
Study, 1997- 2000. Presented at Teratology Society Meeting June 26 - July 1, 2004. Vancouver,
British Columbia, Canada.
296. Reefhuis J, Honein MA, Rasmussen SA, Correa A, Hobbs CA, Scheuerle A, Schieve L, and the
National Birth Defects Prevention Study. Assisted reproductive techniques and the risk of oral
clefts: data from the National Birth Defects Prevention Study, 1997-2000. Am J Epidemiol 2004;
159(11):S7.
297. Reefhuis J, Honein MA, Rasmussen SA, Correa A, Hobbs CA, Schieve L, and the National Birth
Defects Prevention Study. Fertility treatments and neural tube defects, oral clefts and hypospadias:
Updated March 31, 2015
46
Data from the NBDPS, 1997-2001. 2004 Teratology Society Meeting, Vancouver, British
Columbia.
298. Schmidt RJ, Romitti PA, (2004) Maternal caffeine intake and risk of neural tube defects (NTDs).
(Poster presentation at the University of Iowa Research Week).
299. Werler et al. Over-the-Counter Medication Use in the National Birth Defect Prevention Study.
Presented at National Center on Birth Defects and Developmental Disabilities Conference in
Washington D.C. in July 2004.
2003
300. Browne et al. Maternal caffeine consumption and risk of cardiovascular malformations in the
National Birth Defects Prevention Study. APHA Meeting, San Francisco, CA, 2003.
301. Carmichael et al. Maternal smoking and risk of hypospadias in the National Birth Defects
Prevention Study. APHA Meeting, San Francisco, November 2003.
302. Edmonds LD. The National Birth Defects Prevention Study. APHA Meeting, San Francisco, CA,
2003.
303. Ghaffar S, Cleves M, Zhao W, Hobbs CA. The Association between Congenital Heart Defects and
Small for Gestational Age. American Heart Association 2003 National Meeting. (NBDPS National
Data) and one to Cardiac Young Investigator Award. American Acad. Pediatrics 2003 Conf.
(Arkansas data).
304. Hobbs CA. Collaborative Strategies for Unraveling the Complexity of Birth Defects. University of
Arkansas for Medical Sciences, College of Medicine, The 5th Annual Meeting of the North
American Diabetes-In-Pregnancy Study Group. Little Rock, Arkansas. May 4, 2003.
305. Krakowiak PA, Cleves MA, Guan Y, Freeman WA, Greenhaw JJ, Kimbrough J, Lyle RE, Jernigan
S, Zhao W, Hobbs CA. Quality of human DNA from buccal cytobrushes depends on storage
conditions. American Society for Human Genetics (ASHG) Annual Conference. Los Angeles,
California. November 8, 2003.
306. Krakowiak PA, Cleves MA, Guan Y, Freeman WA, Greenhaw JJ, Kimbrough J, Lyle RE, Jernigan
S, Zhao W, Hobbs CA. Quality of human DNA from buccal cytobrushes depends on storage
conditions. Poster. Am J Hum Genet. 2003;73:A1412:411.
307. Krakowiak PA. Dry buccal update. National Birth Defects Prevention Study Annual Meeting, San
Francisco, California. November 13, 2003.
308. Krakowiak PA. Genetic Factors and Birth Defects. ACHRI Scientific Advisory Board, ACHRI,
Little Rock, AR. November 21, 2003.
309. Lin AE, Botto L, Ghaffar S, Cosper C, Correa A, and the National Birth Defects Study.
Classification of cardiovascular malformations in the National Birth Defects Prevention Study. Am
J Hum Genet 2003:73S, 15A. Platform presentation at the Am Soc Hum Genet Meeting Los
Angeles, October 2003.
310. Lin AE. Classification of cardiovascular malformations in the National Birth Defects Prevention
Study UCLA Dept. Pediatrics, Division of Cardiology Seminar. October 29, 2003.
311. Lin AE. The National Birth Defects Prevention Study. The New England Regional Genetic Group
(NERGG) Annual Meeting. Durham, NH, December 4, 2003.
Updated March 31, 2015
47
312. Louik C, Honein M, Werler M, Hernandez-Diaz S, Mitchell AA. Herbal Use in Pregnancy: A Tale
of Two Studies. National Children’s Study Workshop, Use of Herbal Products in Pregnancy,
Breastfeeding, and Childhood. December 16, 2003, Atlanta, GA.
2001
313. Hobbs CA. Arkansas Children's Hospital Research Institute. Scientific Advisory Meeting.
Arkansas Center for Birth Defects Research and Prevention. Little Rock, Arkansas. February 9,
2001.
314. Simmons CJ, Hopkins SE, Fulton CA, Hobbs CA. Sources of Variability in Birth Defects
Prevalence Rates. Frontiers in Fetal Health: A Global Perspective. 2001;3:55.
2000
315. Hobbs CA. Arkansas Perinatal Board. Birth Defects Surveillance, Research, and Prevention in
Arkansas. Little Rock, Arkansas. September 29, 2000.Scheuerle AE, Wright D. Ethical Issues
Encountered in the Establishment of the Texas Birth Defects Research Center. Poster presented at
the American College of Medical Genetics Annual Meeting, March 9-12, 2000, Palm Springs,
CA.Agopian, A. J., Tinker, S. C., Lupo, P. J., Canfield, M. A., & Mitchell, L. E. (2013). Proportion of
neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol, 97(1),
42-46.
Updated March 31, 2015
48
| File Type | application/pdf |
| Author | CDC User |
| File Modified | 2015-04-24 |
| File Created | 2015-04-24 |